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AGRAN U LOGY TOSIS 
INTRODUCTION 
The blood dyscrasias produced by adverse reactions to 
drugs are a diverse group. They take the form of cytopenias 
occurring infrequently and generally unpredictably. To date 
more than 350 drugs have been associated with haematological 
disorders (American Medical Association Registry on Adverse 
Reactions) . 
It is beyond the scope of this work to consider these 
dyscrasias in detail, though the five major ones will be 
considered briefly. These are: - 
1. Thrombocytopenia 
This is characterised by a depressed platelet count. The 
normal platelet count is 250,000 - 350, 000 per cmm. falling in 
thrombocytopenia to 40, 000 per cmm. or less when the symptoms 
of thrombocytopenic purpura appear, these being localised 
or general haemorrhage. This condition can be induced by 
such drugs as Dedormid (allylisopropylacetylurea) and quinidine. 
Thrombocytopenia has been shown to be an immune reaction by 
the demonstration of drug - dependent antibodies against platelets. 
(Sedormid antibodies - Ackroyd 1953, quinidine antibodies - 
Bolton 1956). 
2. Haemolytic anaemia 
This condition is characterised by a persistent anaemia 
2. 
with a resulting reticulocytosis. Haemolytic anaemia is in 
some instances an immune reaction as evidenced by the 
demonstration of drug- dependent Coombs - positive red cell 
antibodies. An example of a drug acting in this way is 
Stibophen (Snapper et al 1953, Harris 1956). 
Haemolytic anaemia as a drug- induced blood dyscrasia 
is also relatively frequent among individuals who have a 
heritable deficiency of the enzyme glucose -6- phosphate 
dehydrogenase. This deficiency renders the individual 
sensitive to the toxic actions of certain oxidant drugs such as 
pamaquin (Carson 1956, Tarlov 1962). 
3. Megaloblastic anaemia 
A state of macrocytosis is found in this condition. The 
bone marrow picture is similar to that found in folic acid 
deficiency. It is thought that drugs inducing megaloblastic 
anaemia e.g. hydantoin derivatives, interfere with folic acid 
metabolism in the bone marrow (Flexner 1960). 
4. Aplastic anaemia 
This is manifested by a reduction in the formative 
elements of the bone marrow, though the degree of depression 
of the various cell lines is variable. About one half of the 
reported cases are considered to be idiopathi5 though many 
3. 
may have resulted from undisclosed exposure to drugs or Î wo 
other noxious agents. T-he drugs commonly associated with 
aplastic anaemia are benzene (Hunter, 1939) and 
chloramphenicol (Registry). Drug- dependent antibodies have 
not been demonstrated. 
Aplastic anaemia has the highest fatality rate of all 
blood dyscrasias. 
5. Agranulocytosis (granulocytopenia). 
In this condition there is a decrease in the number of 
circulating and marrow granulocytes. It is the most 
frequent blood dyscrasia constituting 40% of all cases 
reported to the Registry on Adverse Reactions. Table 1 
shows the number of cases of agranulocytosis due to certain 
drugs. Almost all cases have resulted from long -term 
therapy with these drugs. 
Since this work has been concerned with those drugs 
inducing agranulocytosis this condition will be considered 
in more detail. 
4. 
Table 1. Incidence of agranulocytosis 
Drug 
Cases of agranulocytosis 
Drug alone* Total + 
Chlorpromazine 83 194 
Thiouracil 19 25 
Amidopyrine 14 65 
Phenylbutazone 17 44 
Chloramphenicol 18 75 
Tetracycline 1 47 
Sulphis oxazole 9 48 
* Drug inducing agranulocytosis was the only drug 
administered. 
+ All cases of agranulocytosis, due to the drug alone and also 
where other known toxic drugs were administered along with 
the named drug. 
AGRANULO CY T OSIS 
with particular reference to amidopyrine. 
1. The symptoms of agranulocytosis 
Agranulocytosis as a clinical entity was first described 
by Schultz in Germany in 1922. It is characterised by a 
5. 
marked leucopenia with a white cell count falling as low as 
500 /cmm. (normal range 5, 000 - 10, 000 /cmm. ). The 
percentage of granulocytes falls until none may be present. 
The bone marrow generally shows a virtual absence of 
granular cells and their precursors. These symptoms are 
generally accompanied by sore throat, fever and prostration. 
In fulminating cases the patient dies within a few days from 
toxaemia and septicaemia. 
2. The occurrence of agranulocytosis 
The incidence of this dyscrasia is more frequent in 
women than in men, 70 -80% of cases occurring in women 
generally in the age group of 40 -60 years. The patient 
generally has a history of having taken a drug occasionally or 
for prolonged periods. (Plum and Thomsen 1940, Borglin 
o and Mánsson 1951). 
Using rats, Borglin and. Mánsson (1951) showed that 
castrated females were more susceptible to the central toxic 
actions of amidopyrine (convulsions with subsequent death) 
than normal females, normal males, and castrated males. 
Administration of oestrogens to castrated females restored 
their resistance to the toxic actions of amidopyrine to the 
level of normal females. It was therefore suggested that 
6. 
the higher incidence of agranulocytosis in women aged 40 -60 
years might be due to the decreased oestrogen levels at that 
period of life. 
3. Theories of the aetiology of agranulocytosis - historical 
a) Bacterial toxins In 1924 Lovett examined a patient 
with diagnosed diphtheria who had a negligible granulocyte 
count. He was able to isolate Bacillus pyrocyaneus from the 
patient's blood; on injecting a culture of this micro -organism 
into guinea pigs he observed a granulocytopenia to develop 
after five days. He therefore suggested that 
agranulocytosis could be due to:- 
a) a local infection with some specific micro - organism 
which had a direct toxic action on the bone marrow; 
b) an injury to the granulocytes during the maturation 
period which led to a consequent lack of resistance to infection. 
Dennis (1933) found he could produce a sustained 
leukopenia in rabbits by inserting a plastic capsule containing 
a culture of Streptococcus viridans into the abdominal cavity, 
this organism having been isolated from a case of fatal 
agranulocytosis. The culture remained in the capsule while 
the toxins diffused out. He obtained inconclusive results 
using cultures of Staphalococcus aureus, Streptococcus 
7. 
haemolyticus and Bacillus proteus, all these organisms being 
isolated from the same case of agranulocytosis. Since the 
pathogenic factor was diffusable, he suggested that a leucocidin 
rather than a specific micro -organism was responsible for the 
phenomenon of agranulocytosis. 
A bacterial aetiology for agranulocytosis is unlikely 
since it has been clearly shown (Roberts and Kracke 1930) 
that the basic pathology is:- 
a) a disappearance of granulocytes, and 
b) a subsequent bacterial invasion. 
b) Glandular dysfunction Corey and Britton (1932) 
observed that the removal of the adrenals in cats and rabbits 
led to a marked leucopenia, though not to a characteristic 
agranulocytosis. The leucopenia could be corrected by 
administration of cortico- adrenal extract. It was suggested 
that agranulocytosis was associated with adrenal insufficiency. 
c) Vitamin deficiency On feeding monkeys a diet 
deficient in vitamin G (B2), Day et al (1935) found a slight 
leucopenia to occur, the granulocytes being reduced more than 
the other cell types. Since a typical/ag ranulocytosis was not 
obtained they were unconvinced that the vitamin deficiency was 
the cause of the leucopenia. 
8. 
d) Bone marrow idiosyncrasy In the course of fatal 
agranulocytosis, the leucopenic state, with an absence of 
granulocytes, persists until death, although the marrow may be 
hyperplastic (Fitz -Hugh and Krumbhaar 1932). This finding led 
to the conclusion that the agent causing agranulocytosis either: - 
a) arrested the maturation of the granulocytes at their 
formative centres, or 
b) produced degenerative changes in the cells before 
they were sufficiently developed for their normal migration into 
the blood stream. 
e) A chemical aetiology In 1910 Selling observed that 
persons working in a tin can factory, where large quantities of 
benzene were used, showed a high incidence of leucopenia. He 
was able to produce similar leucopenic states in rabbits by the 
injection of benzene. He concluded that the leucopenia was the 
results of a direct toxic action of the benzene on the blood cells. 
Somewhat later (Kracke 1931), a case of recurrent 
agranulocytosis was observed in a woman who had a history of 
taking large doses of coal tar derivatives. It was postulated 
that the probable aetiological factor in this case was a substance 
containing benzene or one of its derivatives. Further 
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being shown that the increasing incidence of agranulocytosis could 
be correlated with the increasing usage of such drugs as 
amidopyrine, acetanilide, arsphenamine and neoarsphenamine. 
All these drugs contain a benzene ring. The theory was advanced 
that the common factor between these drugs when degraded in the 
body was an oxidation product of benzene (Fig. 1), and that it was 
this oxidation product which was the agent responsible for 
inducing agranulocytosis. In support of this idea was the 
observation that an apparent state of agranulocytosis could be 
produced in rabbits by the injection of catechol or quinone. 
4. The aetiology of agranulocytosis - Current ideas 
a) The drug acting as a hapten In 1931 Pepper noticed 
that almost all of his patients who experienced agranulocytosis 
had a history of some type of allergy, suggesting that some type 
of allergic reaction was involved in agranulocytosis. 
Madison and Squier (1934; Squier and Madison, 1935) while 
supporting the idea that an oxidation product of benzene was the 
aetiological factor responsible for the occurrence of 
agranulocytosis, put forward the view that this adverse reaction 
was not due to a direct toxic action but rather to an allergic or 
anaphylactoid hypersensitivity reaction. This idea stemmed 
from their observations that when a test dose of amidopyrine 
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was administered to an amidopyrine- sensitive patient, a rapid 
and profound leucopenia developed which subsequently recovered 
spontaneously. 
Similar results were obtained by Benjamin and Biederman 
(1934). Since scratch tests, intracutaneous tests, and passive 
transfer tests using amidopyrine- sensitive serum all yielded 
negative results, they proposed that agranulocytosis was due to a 
drug hypersensitivity reaction with the haemopoietic system 
acting as the shock organ. 
Leucocyte agglutinins were first demonstrated by Moeschlin 
and Wagner (1952). Using serum from an amidopyrine- sensitive 
patient who had just received a test dose of the drug they w$ w 
able to show 'in vitro' agglutination of leucocytes taken from both 
the sensitive patient and normal donors. They also demonstrated 
that 500 ml. of whole blood taken from an amidopyrine- sensitive 
patient immediately following a test dose when transfused into a 
normal donor, resulted in a pronounced fall in the circulating 
granulocyte count of the recipient within 30 minutes, followed by 
a spontaneous recovery in around four hours. 
The mechanism of leucocyte agglutination is as yet not 
fully understood. Following ingestion of the drug there are two 
ways in which antibody (Ab) formation might occur: 
11. 
i) the drug itself may act as the antigen (Ag); this 
is unlikely due to the small size of drug molecules; 
ii) the drug molecule may act as a hapten which, when 
combined with a protein, forms an Ag which in turn induces Ab 
formation. This protein is a soluble plasma protein and not a 
leucocyte protein since, firstly, although the drug will combine 
with the leucocyte the bond between the two is so weak that a 
quick wash will remove the drug. For a hapten - protein complex 
to induce Ab formation the bond between the two must be very 
stable (Shulman, 1964), and, secondly, agglutination tests with 
strongly positive sera produce agglutination of heterologous as 
well as of homologous leucocytes (Moeschlin, 1958). 
The anti -amidopyrine Ab appears to be a thermostable 
gamma globulin, whose antigenic activity is directed against the 
61A- 
phenazone group in amidopyrine, and alsoLto a lesser extent in 
similar compounds which contain a phenazone group. 
(Thierfelder et al 1964). 
Moeschlin (1958), from his studies of amidopyrine- induced 
agranulocytosis, considered that after induction of the Ab by the 
haptenic determinant of the drug - protein complex, the Ab became 
fixed to the cells; reintroduction of the drug caused an Ag -Ab 
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reaction, with agglutination of the leucocytes and their 
subsequent destruction. 
Shulman (1964) in his review of quinine and quinidine- 
induced purpura and of Stibophen- induced haemolytic anaemia, 
considered that following Ab induction and reintroduction of the 
drug, that the first reaction was of the Ab with the Ag. The 
Ab -Ag complex was then adsorbed nonspecifically by the cells, 
the ad-sorption being determined by the size, configuration, and 
charge of the Ag -Ab complex and of the cellular adsorption sites. 
Agglutination followed aassorption of the complex. 
Much more is known about antibodies against platelets and 
red cells than against leucocytes. The information concerning 
all three cell types is, in the main, very similar. 
Leucocyte agglutination results in massive peripheral 
leucocyte destruction which stimulates the release of mature, 
and later of immature, granulocytes from the marrow, the 
marrow eventually becoming hypoplastic. 
Leucocytes agglutinated in vivo' are removed from the 
circulation by the lung capillaries (Bierman et al 1951; 
Weisberger and Heinle 1951). 
-..t;c Q-ec 
Not all cases oftagranulocytosis are accompanied by 
detectable antibodies. It seems possible that most cases 
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are due to Ab formation since very few instances are known 
where an attack has begun in less than 5 -7 days which is the time 
required for Ab formation. The fact that Ab's frequently cannot 
be demonstrated may well be a fault in the methods of Ab 
detection. 
b) An abnormally high drug concentration If abnormally 
high concentrations of a drug in the blood were produced, for 
instance by increased absorption, decreased excretion, or 
decreased detoxification, then normal cells might be damaged. 
Alternatively, if a cell were sensitive to a drug at a normal 
therapeutic blood concentration, the same effect would be 
observed. This toxic mechanism is found in individuals who 
have a heritable deficiency of erythrocytes glucose -6- phosphate 
dehydrogenase, which renders the erythrocyteto susceptible to 
the toxic actions of certain oxidant drugs such as pamaquin. 
c) A metabolic abnormality It is conceivable that a 
susceptible individual could metabolise a drug to an abnormal 
metabolite or else to a metabolite which is not toxic to normal 
subjects. An abnormal metabolite might have unusually potent 
antigenic properties. A metabolic abnormality has not been 
demonstrated. 
d) Drug acting as an antagonist A drug or one of its 
14. 
metabolites could antagonise a metabolic pathway which is vital in 
a sensitive person, but which is not vital in normal individuals due 
to the availability of other pathways. This has not been 
demonstrated. 
None of these proposals for the aetiology of agranulocytosis 
can explain all cases. It is probable that a number of factors in 
combination render an individual sensitive to the toxic actions of 
a drug. 
THE PRESENT WORK 
Only a small proportion of the population is liable to 
experience agranulocytosis, this blood dyscrasia being induced by 
one of a large number of drugs. It is not known what factors 
predispose these individuals to this drug- induced condition. 
Since polymorphs are affected to a much greater extent that 
lymphocytes by these drugs,it was decided to investigate the 
actions of some drugs known to induce agranulocytosis on certain 
'in vitro' metabolic reactions of human peripheral leucocytes,to 
determine if there were any metabolic differences between these 
two leucocyte types. 
Initially it was hoped to observe the effects of the drugs on 
bone marrow maturation as determined by changes in cell 
morphology. However, on reading the literature it soon became 
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evident that a method for culturing marrow 'in vitro', such that 
maturation proceeds as 'in vivo', does not exist, despite the 
efforts of many workers over the last thirty years. The use of 
peripheral leucocytes was considered justifiable since there is 
little evidence to suggest that the metabolism of circulating 
granulocytes is basically different from their metabolism in the 
marrow, (Seitz, 1965). The use of peripheral blood had the 
advantage that normal blood is readily available, whereas normal 
marrow is not easily obtained, and also that leucocytes can be 
separated into their constituent cell types largely free from other 
cell types, while marrow is a heterogeneous mixture of cells. 
Recently rat marrow has been partially separated by means of a 
glasswool column to remove most of the granulocytes, followed 
by centrifugation of the remaining cells through a dextran density 
gradient system. At the moment this method yields only lymphoi 
cells, but it should be possible to develop it such that myeloid 
cells can be recovered (Morrison 1967, Morrison et al 1968). 
When proposing reasons why some individuals are more 
sensitive to the toxic actions of these drugs than are other 
individuals, certain factors common to all cases of 
agranulocytosis must be borne in mind: 
i) the incidence of agranulocytosis is low for all drugs; 
ii) drug- induced agranulocytosis occurs after the 
administration of normal therapeutic doses over a period of 
time varying from a week to several months; 
iii) agranulocytosis is not a side -effect since 
a) its occurrence is unpredictable, and 
b) its occurrence is in no way related to the normal 
pharmacological actions of the drugs. 
One possible explanation which could account for these 
observations is that there is a genetic factor inducing 
susceptibility to agranulocytosis, but as yet there is no 
evidence for this. Hereditary factors have been shown to be 
involved in certain other conditions such as the heritable 
deficiency of erythrocyte glucose -6- phosphate dehydrogenase, 
and the heritable deficiency of pseudocholinesterase which 
renders individuals highly sensitive to the actions of 
suxamethonium (Lehmann and Liddell, 1962). A familial 
incidence of aplastic anaemia due to chloramphenicol has also 
been reported (Rosenthal and Blackman, 1956). 
Before any hereditary metabolic abnormality could be 
demonstrated it was necessary to determine the normal 
metabolic characteristics of leucocytes, and also the effects 
of drugs thereon. This was the primary objective of the 
16. 
17. 
present work. If it could be demonstrated that leucocytes 
obtained from drug- sensitive patients, and also from their 
siblings, had different metabolic characteristics with regard 
to the effects of the sensitising- drugs, then some evidence for 
a hereditary factor inducing susceptibility to agranulocytosis 
would be suggested. 
SECTION Z 
SEPARATION OF LEUCOCYTES AND THE 
MEASUREMENT OF LEUCOCYTE OXYGEN UPTAKE 
18. 
THE METABOLIC PARAMETERS TO BE STUDIED 
Following the decision to use pl/ieripheral blood leucocytes 
it was necessary to find suitable metabolic parameters for 
investigation. There were two alternative approaches to this 
question: - 
a) investigate the effects of the drugs on specific enzyme 
systems, or 
b) investigate the effects of drugs on metabolic processes 
involving a number of enzymes. 
The second method was used in the initial studica since it 
was thought more likely that a drug effect would be observed on 
a number of enzymes rather than on a single enzyme. 
The first metabolic reaction selected for investigation was 
the cell respiration, this parameter being chosen because it is 
an indicator of the general metabolic integrety of the cell, and 
also because it is fairly easily measured. 
A number of preliminary experiments were performed to 
check that the leucocyte respiration was measurable, to 
determine the best method for expressing the results, and to 
determine if any drugs showed a noticable effect on leucocyte 
respiration. 
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Rabbit leucocytes were used in these experiments, 
leucocyte -rich suspensions being prepared using the buffy -coat 
technique, the respiration being measured in a conventional 
Warburg apparatus. The results of these experiments were 
as follows: - 
a) Using leucocyte concentrations of 12 -118 x 10 
ïeucocytes /Warburg flask the rate of oxygen uptake 
(= respiration) was found to range from 4 -37 N.L/hour which was 
quite measurable. 
b) If the oxygen uptake was proportional to the number of 
leucocytes being used it would be legitimate to express all the 
results in the same units. However if the oxygen uptake was 
not proportional to the leucocyte concentration all experiments 
would have to be performed using the same leucocyte 
concentration to allow the results to be expressed in terms of 
the same units. A number of experiments were done to 
estimate the oxygen uptake using varying leucocyte concentrations 
A graph was then plotted of the oxygen uptake in µl/hour /1010 
leucocytes against the number of leucocytes /Warburg flask 
(Fig. 12). No apparent crowding effect was observed, that is 
as the leucocyte concentration increased the oxygen uptake /hour/ 
6 
1010 leucocytes did not decrease. It thus seemed legitimate to 
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express all the results in the same units regardless of the 
number of leucocytes per flask. 
c) Chloramphenicol at 4.0 x 10 -3M was found to inhibit 
the respiration by about 60%, while 1.0 x 10-3M inhibited by 
about 33%. This indicated that inhibitory effects of the drugs 
should be measurable. 
The second metabolic parameter which was investigated 
was the leucocyte lactic acid production. This parameter was 
chosen because leucocytes are known to exhibit the Pasteur 
effect, that is when the respiration is depressed, for instance 
by a reduced oxygen tension, then the lactic acid production is 
stimulated (Hedeskov and Esmann, 1966; Bird, 1951; this work 
Section 3, page 72. , Fig. 20). 
SEPARATION OF LEUCOCYTES FROM WHOLE BLOOD 'IN VITRO 
20 
It was mentioned on page PI that chloramphenicol was 
found to inhibit leucocyte respiration. However since blood 
contains two main leucocyte types - polymorphonuclear 
leucocytes (polymorphs or PMN) and lymphocytes - it was not 
possible to determine whether both cell types were being 
affected, or whether only one type was being inhibited. It 
was therefore necessary to find a method for separating these 
two cell types. 
21. 
In the past many observations on the biochemical behaviour 
of human leucocytes have been made on normal unseparated 
suspensions because it was not possible to separate the cell 
types. Leukaemic leucocytes have also been used since it 
was possible to obtain relatively pure suspension of these cells. 
However these are not normal cells. For instance the 
respiration of normal leucocytes is greater than the 
respiration of chronic myeloid leucocytes which in turn is 
greater than the respiration of chronic lymphocytic leucocytes 
(Beck and Valentine 1952) 
Many different methods for isolating leucocytes from 
whole blood have been used with varying degrees of success in 
the past. Very briefly a few of these methods are: - 
a) allowing the anticoagulated blood to sediment giving 
a leucocyte rich supernatant; 
b) centrifuging the blood to give the so- called "buffy- coat" 
where the leucocytes are layered on tope of the erythrocytes; 
c) centrifuging the blood sample in a waisted tube of 
such a size that the leucocytes collect in the narrow section of 
the tube in three distinct layers, these being, from top to 
bottom, lymphocytes, PMN, and erythrocytes (Haight and 
Rossiter 1950, Ventzke et al 1959). 
22. 
d) centrifugation through a sucrose gradient (Archdeacon 
Stol -o 
et al 1964, Stollof and Weiss 1963). 
e) centrifugation through bovine serum albumin of specific 
gravity about 1. 079, the leucocytes sinking to the bottom 
(Vallee et al 1947). 
f) addition of high molecular] ubstances such as dextran, 
fibrinogen, or phytohaemagglutinin, causing rouleaux formation 
of the erythrocytes with a subsequent rapid sedimentation of 
these cells. Dextran and fibrinogen are more efficient than 
phytohaemagglutinin (Skoog and Beck 1956). Phytohaemagglutinin 
is frequently used in chromosome studies since it promotes 
mitosis. 
Animal leucocytes may be obtained in almost pure 
suspensions by the injection of certain substances into the 
abdominal cavity. Saline causes the migration of PMN (Rossi 
and Zatti 1964), and turpentine the migration of lymphocytes 
(Allison et al 1961). It is doubtful if these leucocytes are 
entirely normal since their migration is the result of a 
stress reaction. Animal lymphocytes can also be obtained in 
pure suspensions from the thoracic lymph ducts (Bollman et al 
1948). 
23. 
SEPARATION OF LEUCOCYTES BY THE GLASS BEAD 
COLUMN METHOD 
A considerable advance in the technique of cell separation 
was made by Johnson and Garvin in 1959. They found that if 
heparinised human blood was passed through a column of 
siliconed glass wool contained in a glass tube, the PMN were 
retained while the lymphocytes and erythrocytes passed straight 
through. Garvin (1961) investigated this phenomenon and found 
that if glass beads were used instead of glass wool, the PMN 
were still retained but could be recovered by washing the 
column with a calcium -and magnesium -free solution containing 
0.02% of ethylene diamine tetraacetic acid, disodium salt 
(EDTA). The optimum conditions for PMN retention were found 
to be 
i) a long glass bead column, 
ii) a slow flow rate when eluting the column to remove 
lymphocytes and erythrocytes (eluting fluid was plasma), 
iii) pH 7.4, 
iv) a temperature of 37oC, and 
v) calcium and magnesium must be present. 
This method for separating PMN from lymphocytes was 
quantitated by Rabinowitz in 1964. This method with some 
modifications has been used in this work. 
DIAGRAM OF COLUMN USED 
FOR LEUKOCYTE SEPARAT ION 
- ELUTING FLUIDS-37°C 
SCREW CLIPS TO CONTROL 
FLOW RATE 
GLASS BEADS 
WATER JACKET -37 °C 
GLASS WOOL PAD 
SCREW CLIP TO CONTROL 





1. Principles of the separation procedure 
A leucocyte -rich suspension was prepared using the buffy- 
coat technique, the leucocytes being resuspended in plasma to a 
volume suitable for the column being used. The leucocyte 
suspension was added to the column and incubated at 37oC for 
30 minutes. The leucocytes were removed from the column by 
washing with 
i) 80% Hanks BSS + 20% plasma, pH 7. 4, giving 
erythrocytes and lymphocytes; 
ii) a Ca +-I-- and Mg +-I-- free solution containing 0.02% 
EDTA, pH 7.4, giving PMN. 
2. Materials 
Blood in 20 ml and 100 ml volumes was obtained from 
haematologically normal volunteers. Large volumes (400 ml) 
were obtained from the Blood Transfusion Service, Royal 
Infirmary, Edinburgh. This blood was generally from donors 
with a past history of infectious hepatitis, the haematological 
picture being normal. Preservative -free heparin (10U /ml) was 
used as the anticoagulant. 
Fig. 3 shows the apparatus used. The glass column was 
made from Pyrex tubing, its size being 1.0 cm. diameter x 20 cm 
height for 20 ml. blood samples,l.5 x A, or 2.5 x 35 cm. 
567 
25. 
columns were used for the larger blood samples. The column 
was surrounded by a water jacket. 
The glass beadsa had a mean diameter of 0.2 mm., a 
volumn of 4.19 x 10-6 cc., and a surface area of 1.26 x 10 -3 cm2. 
Each centimeter of the 1.0 x 20 cm. column contained 106, 000 
SOU 
beads (Garvin, 1961). A s, rll pad of glass wool was placed at 
the bottom of the column to retain the beads. The beads were 
discarded after use. 
All glassware with which the blood came into contact was 
siliconed. Initially Repelcote b was used but this appeared to 
give a poorly siliconed surface. For this reason the silicone was 
changed to M441 c for all the glass except the beads which were 
siliconed with the water -soluble silicone Silicladd. After 
siliconing, all glassware was washed 10 times in tap water and 10 
times in glass -distilled water. After use siliconed glass was 
soaked in Decon 75 e overnight, followed by 20 tap water washes 
and 10 distilled water washes. After three experiments the 
silicone was removed with chromic acid, the glass then being 
re- siliconed, All other glassware was cleaned with chromic acid 
after each experiment and washed as indicated above. 
All centrifugation was carried out in an M.S.E. Super 
Multex swinging -arm centrifuge. 
26. 
Erythrocyte and nucleated white cell counts were íße 
using an Improved Neubauer counting chamber. 
Differential leucocyte counts were initially performed 
using Leishman stain. It was later found that the 
differential counts could be made at the same time that the 
nucleated cell counts were done. Not only was this easier 
than making smears, but the results were more reproducible 
and were within 1% of counts made with stained smears. 
a Ballatoni grade number 11 : Jencons 
(Scientific) Ltd., Hemel Hempstead, Herts. 
b Repelcote; Hopkins and Williams Ltd. 
c M 441 Silicone : I. C.I. 
d Siliclad : Clay -Adams Inc. , New York. 
Distributed by Arnold R. Horwell Ltd., London. 
e Decon 75 : Medical Pharmaceutical Developments Ltd. 
27. 
3. Solutions 
1) Hanks buffered salt solution (hereafter Hanks) : 
Sodium chloride 8.00 gm. /litre 
Potassium chloride 0.40 gm. /litre 
Calcium chloride, 6H20 0.14 gm. /litre 
Magnesium sulphate.7H20 0.20 gm. /litre 
Disodium hydrogen ortho phosphate 0.12 gm. /litre 
Potassium dihydrogen 
orthophosphate 0.06 gm. /litre 
Sodium bicarbonate 0. 35 gm. /litre 
Glucose 1.00 gm. /litre 
Distilled water to 1000 ml 
This solution when mixed with 20% plasma was used as 
the lymphocyte (and erythrocyte) eluting fluid. 
2) 0.02% EDTA solution 
Ethylene diamine tetraacetic 
acid, dsodium salt (EDTA) 0.20 gm. /litre 
Sodium chloride 8.00 gm. /litre 
Potassium chloride 0.20 gm. /litre 
Disodium hydrogen orthophosphate 1.15 gm. /litre 
Potassium dihydrogen orthophosphate 0.20 gm. /litre 
Glucose 0.20 gm. /litre 
Distilled water to 1000 mis 
28. 
This solution was used as the PMN eluting fluid. 
Plasma was added to the collecting tubes to a final 
concentration of 20%. 
3.) Adjustment of pH 
The pH of both of these solutions was adjusted to 
pII 7.4 using 0.5N hydrochloric acid or 0.5 N sodium 
hydroxide. 
4. Separation of Leucocytes - Procedure 
a) Human Blood The leucocyte separation method 
was tested using 20 mis. human peripheral blood obtained via 
the intracubital vein. In these experiments the leucocyte -rich 
suspension was prepared using the buffy -coat technique since 
this method has been used successfully by numerous workers 
(e.g. Rubini et al 1961, Schultz and Kaminker 1962, Ohta 1964). 
The leucocytes were resuspended in 2 -3 mis. plasma and applied 
to a 1.0 x 20 cm. glass bead column. A gentle positive pressure 
at the tope of the column was required to induce the suspension 
onto the column. After leaving the suspension on the column 
for 30 minutes, the lymphocytes (and erythrocytes) and PMN 
were eluted from the column using the solutions detailed above; 











































































































































































































































































































































































































































































































































































































































































































results of these experiments. There would appear to be a 50% 
loss of PMN but only a 25% loss of lymphocytes. 
b) Rabbit blood A number of separations were 
attempted using animal blood, the potentional advantage over 
human blood being that the effects of administration of the 
drugs over a period of time could be investigated. 
It was felt inadvisable to use small animals such as rats, 
since the volume of blood obtainable from a single animal would 
be small, and so would necessitate mixing the blood from 
several animals. For this reason rabbits of 2 -3 Kg were used. 
These animals yielded up to 100 mis. blood by cardiac puncture 
under nembutal anaesthesia (60 mg. /Kg.) administered via the 
ear vein. A 20 gauge needle on a polythene canula was 
inserted into the heart, the blood being allowed to flow into a 
tube containing 10U /ml. heparin. The first 50 ml, came 
rapidly, the second 50 ml. requiring gentle suction from a 
syringe on the end of the canula. On attempting to perform a 
separation of the leucocytes in an identical manner to that 
successfully used for the human blood, the leucocyte -rich 
suspension was found to clot on the column. Increasing the 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































suspension 1004.0 58.0 : 42.0 594 410 
Hanks: 
0 - 10 155.0 15.7 : 84.3 24.3 4.1 130.7 31.8 
10 - 20 111.0 5.3 : 94.7 5.9 1.0 105.1 25.6 
20 - 30 66.0 7.0 : 93.0 4.6 0.8 61.4 15.0 
30 - 40 25.2 13.0 : 87.0 3.3 0.6 21.9 5.4 
40 - 50 11.6 14.5 : 85.5 1.7 0.3 9.9 2.4 
50 - 60 8.5 32.6'.: 67.4 2.8 0.5 5.7 1.4 
60 - 70 7.4 31.1 : 68.9 2.3 0.4 5.1 1.2 
70 - 80 - - - - - - 
80 - 90 - - - - - - 
90 -100 - - - - - - 
100 -110 6.9 60.0 : 40.0 4.1 0.7 2.8 0.7 
110 -120 - - - - - - 
120 -130 5.5 16.4 : 83.6 0.9 0.2 4.7 1.1 
EDTA: 
O - 10 8.0 83.4 : 16.6 6.6 1.1 1.4 0.3 
10 - 20 196.8 97.2 7 2.8 191.0 32.2 5.8 1.4 
20 30 93.6 94.2 : 5.8 88.2 14.8 5.4 1.3 
30 - 40 35.6 87.4 : 12.6 31.1 5.2 4.5 1.1 
40 - 50 21.2 73.0 : 27.0 15.5 2.6 5.7 1.4 
50 - 60 14.1 95.8 : 4.2 13.5 2.3 0.6 0.1 
60 - 70 8.7 93.0 : 7.0 8.1 1.4 0.6 0.1 
70 - 80 5.6 80.5 : 19.5 4.5 0.8 1.1 0.3 
80 - 90 7.4 89.4 : 10.6 6.6 1.1 0.8 0.2 
EXPT. B. 
Leucocyte 
suspension 330.0 37.7 : 62.3 124 206 
Hanks: 
O - 10 73.0 0.0 :100.0 0.0 0.0 73.0 35.4 
10 - 20 35.2 0.0 :100.0 0.0 0.0 35.2 17.1 
20 - 30 17.6 0.0 :100.0 0.0 0.0 17.6 8.5 
30 - 40 9.9 5.0 : 95.0 0.5 4.0 9.4 4.6 
40 - 50 1.5 9.3 : 90.7 0.1 -' 0 1.4 0.7 
50 - 60 1.3 5.0 : 95.0 0.1 --'0 1.2 0.6 
60 - 70 0.9 2.0 : 98.0 ' 0 ) O 0.9 0.4 
70 - 80 1.0 6.3 : 93.7 ) O ) 0 1.0 0.5 
80 - 90 - - - - - - 
90 -100 - - - - - - 
100 -110 0.6 4.8 : 95.2 .4 O -" O 0.5 0.3 
EDTA: 
0 - 10 1.4 92.0 : 8.0 1.3 1.1 -a0 >O 
10 - 20 41.2 96.0 : 4.0 39.6 32.0 1.6 0.8 
20 - 30 22.1 95.0 : 5.0 21.3 17.2 0.8 0.4 
30 - 40 4.3 95.0 : 5.0 4.1 3.3 0.2 0.1 
40 - 50 1.8 76.0 : 24.0 1.4 1.1 0.4 0.2 
50 - 60 1.1 100.0 : 0.0 1.1 0.9 0.0 0.0 
60 - 70 0.4 78.0: 22.0 0.3 0.2 0.1 -)o 
70 - 80 1.2 88.0 : 12.0 1.1 0.9 0.1 O 
80 - 90 1.0 91.0 : 9.0 0.9 0.7 0.1 > 0 
30. 
clotting. 0.02% EDTA proved unsuccessful in eluting the PMN 
from the column, so this concentration was increased to 0.07%. 
The results of these experiments are given in table 3. On 
comparing this table with table 2, it can be seen that human and 
rabbit lymphocytes give similar yields, while the PMN behave 
quite differently, human PMN being recoverable, rabbit PMN 
being unrecoverable. 
Since it was not possible under these conditions to recover 
rabbit PMN, it was decided to use only human leuco cyte s . 
5. The Eluting Volume Required to Effect Separation 
In order to determine the volume of eluting fluid required to 
elute human PMN and lymphocytes, two experiments were done 
using a 1.5 x 26 cm. column and blood volumes of 50 and 80 mis. 
Following buffy -coat separation of the erythrocytes and 
incubation of the leucocyte -rich suspension on the column, 130 mis. 
of Hanks /plasma solution, and 100 mis. of the 0.02% EDTA 
the 
solution were run through the colu.mn,Ieluate being collected in 
10 ml. aliquots. Nucleated and differential cell counts were 
made on each aliquot. Table 4 shows the leucocyte recoveries 
in each aliquot. A histogram (Fig. 4) was plotted of the mean 







RECOVERY OF LEUCOCYTES DURING 
COLUMN SEPARATION 
COLUMN SIZE : 1.5 cm dia x 1R cm 
ELUTING FLUID : 80°10 "HANKS" 
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ELUTING FLUID :O.02°10 EDTA 
H- 
0 10 20 30 40 50 60 70 80 
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Figure 4. 
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Table 5b. Contamination of leukocytes during column separation 


























* Differential count expressed as % polymorphs: 
% lymphocytes. 
31. 
values being shown in table 5a. Table 5b shows the mean 
contamination of the pooled aliquots. It can be seen that the bulk 
of the lymphocytes are recovered in the first 40 mis.; a similar 
result was obtained for the PMN. In all subsequent experiments 
using this column size the eluting volumes were both 50 -60 mis. 
THE OXYGEN UPTAKE OF SEPARATED LEUCOCYTES 
1. Method 
The apparatus used for the measurement of oxygen uptake 
qßµ 
was a standard Warburg respirometer (Umbreit et al 1-9-5-7j. 
The flask volume was approximately 25 mis. 
A leucocyte -rich suspension was prepared from 80 -100 rnls. 
cf human blood using the buffy -coat technique. Following 
column separation the leucocyte suspensions were centrifuged 
down, the leucocyte pellets being resuspended in Hanks. The 
composition of the Warburg flasks was 
leucocyte suspension in Hanks 1.0 mis. 
plasma 0.8 mis. 
1 Az 5 2. Z mis 
giving a final composition of 1 part plasma : 4 parts Hanks. All 
the flasks were set up in duplicate. The centre well contained 
0.3 mis. of 10% KOH on a piece of filter paper. The flasks were 



































0 10 20 30 40 50 60 70 80 90 100 110 120 
TIME IN MINUTES. 
Figure 5. 
gassed with 100% oxygen for 5 minutes then equilibrated in the 
via ..sr.ev 
water bath at 37oC for 15 minutes before taking any readings. 
Manometer Readings were taken every 10 minutes for 2 -3 hours. 
The flasks were shaken at 120 -130 oscillations per minu 
The flasks were set up as follows: 
flask 1 thermobarometer, 4.0 mis. water; 
flask 2, 3 controls, medium but no leucocytes; 
flask 4, 5 erythrocyte suspension obtained from the 
buffy -coat residue; 
flask 6, 7 lymphocyte suspension; 
flask 8, 9 PMN suspension. 
The erythrocyte suspensions were included to allow for a 
correction to be made in the calculations of the oxygen uptake of 
the two leucocyte suspensions, due to the erythrocyte 
contamination of these suspension. 
2. Calculation of the oxygen uptake 
A graph was plotted of the total oxygen uptake per flask in 
µl against the time in minutes (e.g. Fig. 5). The rate of 
uptake was determined by drawing the best straight line through 
the 20 -70 minute points - the 10 minute point was not included 
since it was invariably very low i.e. the oxygen uptake was 
very high during the first 10 minutes. Similar results have been 




Knowing the rate of oxygen uptake for the erythrocyte 
suspension a correction was made for the erythrocyte 
contamination of the two leucocyte suspensions. Since the 
differential counts of the PMN and lymphocyte suspensions were 
known, the oxygen uptake could be calculated as follows: 
1) if the composition of the PMN suspension is X PMN + Y 
lymphocytes, and the rate of oxygen uptake is Z µL /hour, and 
11) if the composition of the lymphocyte suspension is X' 
PMN + Y' lymphocytes, and the rate of oxygen uptake is Z' µl.1 
hour, 
then the following relationships exists: 
X PMN + Y lymphocytes = Z µL/hour, 
X' PMN Y' lymphocytes = Z' µl./hour. 
On solving these two equations simultaneously, the oxygen uptake 
of the two cell types were obtained, the results being expressed as 
oxygen uptake of PMN (.602 PMN) = A 111f hour /1010PMN 




The results of a number of separations and determinations 
of A02 of separated leucocytes are given in tables 6a (yields), 
6b (DO2's) and 7 (contamination of the suspensions). In 
Table 6a. LEUCOCYTE YIELD AFTER SEPARATION 
Experiment 
no. 

























%PMN : %L x 106 x 106 % x 106 x 106 
0.07% EDTA 
25 498 57.8 : 42.2 288 155 53.8 210 83.2 39,6 
26 723.9 56.5 : 43.5 409 148.4 36.3 314.9 192.3 61,1 
27 720 59.0 : 61.0 425 257.2 60.6 295 206 69,8 
28 326 34.7 : 65.3 113 106.3 94.2 213 100.9 47,4 
mean : 61.2 54,5 
S.E. : 12.12 6,1 
0.02% EDTA 
30 589.4 50.0 : 50.0 294.7 145 49.4 249.7 206 70,8 
34 642 55.1 : 44.9 353 146 41.4 289 180.6 62.1 
35 661.3 55.2 : 44.8 364 168 46.2 297.3 100.6 33,E 
mean : 45.7 55,; 
S.E. : 2.33 I1,1 
Table 6b. OXYGEN UPTAKE OF SEPARATED LEUCOCYTES 
Experiment 
no. 







Polymorphs Lymphocytes Erythrocytes 
0.07% EDTA 
25 16.6 30.9 5.6 1600 2478 10.6 
26 29.6 37.1 3.2 0 3150 -00.31 
27 41.2 64.3 5.5 569 1041 6.45 
28 20.3 26.6 6.4 52 3546 9.1 
mean : 555.34 2553.8 6.5 
S.E. : 334.92 549.63 2.415 
0.02% EDTA 
30 45.8 41.5 6.9 36 1315 5.8 
34 45.1 36.6 8.2 343.3 1957 7.94 
35 25.2 41.9 5.9 114.6 1425 6.5 
mean : 164.6 1565.7 6.7 
S.E. : 92.17 198.21 0.63 
















% PMN %L 
0.07% EDTA Polymorphs Suspension 
25 33.2 30.9 2.3 100 93.0 7.0 
26 39.1 37.1 2.0 140 94.8 5.2 
27 69.2 64.3 4.9 800 92.9 7.1 
28 29.0 26.6 2.4 112 91.8 8.2 
mean : 93.1 6.9 
S.E. : 0.62 0.62 
0.02% EDTA 
30 44.1 41.5 2.6 93 94.4 5.6 
34 44.6 36.6 8.0 224 82.0 18.0 
35 50.8 41.9 8.9 77 82.5 17.5 
mean : 86.3 13.7 
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* Number of leucocytes per Warburg flask 
** Differential count expressed as % polymorphs ( %PMN) 
% lymphocytes ( %L). 
34. 
experiments 25 -28 the PMN eluting fluid was 0.07% EDTA due to 
an error in making up the fluid. The experiments were repeated 
using 0.02% EDTA (nos. 30, 34, 35). It can be seen that this 
resulted in a slightly lower PMN yield. The AO2 values 
appeared lower, but this may just be due to the great variation 
in o02. 
4e Conclusions 
These results were unsatisfactory since they were 
extremely variable, and also they were very low. The results 
can be compared with only two other published papers, since 
only two groups of workers have used this method of spearation. 
A02 PMN : this work 164. 6 
AO2 L 
Rabinowitz (1964) 3600 
Hedeskov and 2600 Esmann (1966) 








µl /hour /1010 
lymphocytes. 
POSSIBLE FACTORS INFLUENCING LEUCOCYTE RESPIRATION 
Since the observed values for AO2 of both leucocyte types 
were so low, an investigation of the various factors which could 
35. 
have been responsible was made. The possibilities considered 
were that: 
i) the leucocytes were being damaged by centrifugation; 
ii) the glass bead separation method was having an adverse 
effect upon the leucocytes; 
iii) for some reason the leucocytes were not viable; 
iv) the pH during the oxygen uptake incubation period was 
changing from the initial value of 7.4; 
v) the medium being used for the measurement of AO 
G 
was unsatisfactory. 
It was also possible that the number of leucocytes used in these 
experiments was too low. When there are few leucocytes in the 
Warburg flasks, the oxygen uptake is necessarily low with a 
consequent inaccuracy in reading the manometer levels. 
1. Damage to leucocytes due to centrifugation 
Up to this stage the leucocyte -rich suspensions had been 
prepared using the buffy -coat technique, which necessitated 
centrifuging at about 300 G. Hedeskov and Esmann centrifuged 
their separated cells at 600 G. 
Rabinowitz states that centrifugation at more than 150 G is 
damaging to the leucocytes. It was therefore decided to try 
using dextran for the sedimentation of the erythrocytes. Two 
ables 8a & 8b. 

















x 106 x 106 % x 10 x 106 % 
195 135 69.0 187 85 45,6 
343 162 47.3 137 76 55,8. 
152 74 48.7 190 114 60,4 
298 89 30.0 135 73 Ni 
341 159 46.7 187 96 51,4 
269 126 46.9 92 54 58,8 
507 226 44.6 209 93 44,9 
173 41 23.5 128 60 463 
mean : 44.6 51,9 
S.E. : 4.80 2A9 
EN UPTAKE OF SEPARATED LEUCOCYTES 
d to 
Oxygen uptake in 9U/hour /1010 cells 
Erythrocytes Polymorphs Lymphocytes Erythrocytes 
x 109 
4.0 429 568 9.6 
3.5 875 1690 21.2 
7.5 1391 996 11.9 
3.8 812 937 23.3 
7.4 772 1008 16.2 
10.4 501 1768 25.7 
7.5 349 1190 9.6 
10.6 1550 1462 19.6 
mean: 834.9 1202.4 17.2 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































types were tried, these being B.D.H. dextran grade B, molecular 
weight 150, 000 - 200,000, and Pharmacia dextran 250, mol. wt. 
250, 000. The Pharmacia dextran was found to give a slightly 
higher leucocyte yield than the B.D.H. dextran; it also 
sedimented the erythrocytenearly twice as fast. For these 
reasons only Pharmacia dextran was used. 
Using dextran a number of determinations of AO2 were made 
The erythrocytes were sedimented by addition of one part of 5% 
dextran in Hanks, pH 7.4, to 5 parts whole blood, and standing 
for 30 -40 minutes at room temperature. The resulting 
erythrocyte -poor supernatant was removed and centrifuged at 
about 130 G for 10 minutes, the leucocytes being resuspended in 
the supernatant to the required volume. The remainder of the 
separation procedure was as indicated previously. The 
Warburg procedure was as usual with the exception that air was 
used as the gas phase since it has been shown that high oxygen 
tensions can exert an inhibitory action on a number of tissue 
enzymes (Dickins, 1946). 
The results are given in tables 8a (yields), 8b(AO2's) and 9 
(contamination of the suspensions). It can be seen that there has 
been an improvement; although the D O2's are still low they are 
more consistent than previously. 
2. The effect of glass bead column separation on 
leucocyte respiration 
It was considered that the passage of the leucocytes through the 
glass bead column could be affecting the leucocytes adversely. 
An experiment was set up to find if this was so. 
The AO' s of three leucocyte suspensions were determined, the 
suspensions being 
i) a dextran -sedimented mixed leucocyte suspension, 
ii) a column- separated PMN suspension, and 
iii) a column- separated lymphocyte suspension, 
all three suspensions originating from the same blood sample. 
The AO2's were found to be 
i) mixed leucocytes - 1016 





iii) lymphocytes - 1115 ) 
'IL/hour/1010 leucocyte s 
( cf. table 8b where mean = 834.9; cf. table 8b where mean. 
= 1202.4) 
The differential count of the mixed leucocyte suspension was 
57.4% PMN : 42.6% lymphocytes. The calculated L O2 of a 
suspension with this differential count using the A02 values 
obtained for the separated leucocytes is 
PMN contribution = 0.574 x 830 








This value for .602 (952) is 93. 6% of the value obtained 
for the mixed leucocyte suspension, comparing favourably with the 
figure of 91% found by Rabinowitz. This experiment was repeated 
somewhat later, identical results being obtained (93.9%). 
It therefore seemed that the column separation procedure 
was not responsible for the low A02 values. 
3. Leucocyte viability tests 
It was possible that both the separated and unseparated 
leucocytes were only partially viable. If so, that would explain 
the experiment above where the A02 was the same before and 
after separation. To test this suggestion, viability stains were 
tried. The theory behind these stains is that viable cells exclude 
the stain while non -viable cells become stained. Two methods 
were attempted: 
(i) Trypan blue method (Rabinowitz 1964). Three drops of 
a leucocyte suspension are added to one drop of a 1% trypan blue 
solution in Hanks at pH 7.4 After incubation at 37°C for 30 
minutes, a normal leucocyte count is made, the counted 















EFFECT OF HEAT (45 °C) ON LEUKOCYTE VIABILITY. 
Expt. 40. - Trypan blue. 
Expt.40. - Eosin. 






30 60 90 
TIME IN MINUTES. 
Figure 6. 






































































































































































































































































































































































































































































































































































































































































































non - viable leucocytes. 
(ii) Eosin method (Hanks and Wallace 1958). A 1:1000 
dilution of eosin in Tyrode solution, pH 7.4, is made up. A normal 
leucocyte count is made using this solution as the diluting fluid. 
The viable cells are unstained, the non -viable cells appearing pink. 
Since some difficulty was experienced when attempting to 
decide whether a leucocyte was taking up the stain, an experiment 
(Expt. 40) was set up such that a leucocyte suspension would 
become completely non -viable over a period of time. 5 mis. blood 
were sedimented with dextran, the erythrocyte -poor supernatant 
being removed. This leucocyte suspension was then incubated at 
45oC in a water bath, viable counts being made at intervals using 
trypan blue and oesin. The experiment (Expt. 41) was repeated 
using trypan blue. The results are given in table 10 and Fig. 6. 
As can be seen from Fig. 6 there is a general trend towards non - 
viability with time, though the degree of non - viability is variable. 
It was found to be extremely difficult to distinguish between stained 
and unstained leucocytes, there being a high degree of subjectivity 
in the numbers of stained /unstained leucocytes counted. 
When applying these viability stains to column separated 
leucocytes it invariably appeared that either all or none of the 
leucocytes were being stained . Since Rabinowitz found 0.2% of 

















































































































































































































































































































































































































































Hedeskov and Esmann found a value of 1%, this suggests that 
essentially all (or none) of the leucocytes separated in this work 
were viable. 
4. pH changes during the oxygen uptake incubation period 
Since the separation procedure seemed to be working 
correctly, the next step to be investigated was the respiration 
determinations. Firstly, the pH was checked to ascertain if it 
had changed significantly from the initial value of 7.4. Two 
experiments were done, the pH being measured at the termination 
of the two hour incubation period. The results are shown in table 
11. It can be seen that the pH rises in all the suspensions. There 
are two possible causes: 
i) KOH contamination of the flask contents. This is unlikely 
since there was no free KOH in the centre -well. Occasionally the 
flask fluid splashed into the centre -well this presumably killing the 
leucocytes. To avoid this detrimental effect on the leucocytes on 
the odd occasion when splashing occurred, the filter paper / KOH 
was placed in the side arm. 
ii) Since Hanks solution contains bicarbonate, it is possible 
that CO2 was being lost. However Rabinowitz used the same 
medium and did not find the pH to rise. 
5. The effect of different media on the pH changes during the 
oxygen uptake incubation period. 
In an endeavour to prevent the pH rising five different media 
were compared; 
i) 100% plasma, pH 7.4; 
ii) 50% plasma + 50% Hanks, pH 7.4; 
iii 50% plasma + 50% 'old' Hanks, pH 7.4. Normal Hanks 
was kept overnight at 37°C. The pH went up, but was 
restored to 7.4 before use. 
iv) 50% plasma + 50% medium 199, pH 7.4; 
IT) 50% plasma + 50% 'phosphate' Hanks, pH 7.4. The 
composition of this medium is similar to Hanks, except 
that the bicarbonate has been omitted and the phosphate 
buffer concentration increased: 
'Phosphate' Hanks solution: - 
Sodium chloride 8.0 gm /litre 
Potassium chloride 0.4 gm /litre 
Calcium chloride, 6H20 
Magnesium sulphate.7H20 
Potassium dihydrogen orthoophosphate 







1.0 gm /litre 
to 1000 mis. 
41. 
THE EFFECT OF DIFFERENT MEDIA ON THE OXYGEN UPTAKE 
OF LEUKOCYTE SUSPENSIONS 
0-0 'phosphate' Hanks; 
6-o plasma ; 
50°10 plasma 50 %0 0-- 'old' Hanks; 
x---x medium 199 ; 
16 
15 
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Since there were insufficient leucocytes from 100 mis. blood to 
compare these media on separated leucocytes simultaneously, mixed 
leucocyte suspensions were used. The results are given in tables 
12 (pH changes) and 13 (AO2's). It will be observed that the 
'phosphate' Hanks kept the pH down better than the other media, and 
also that it gave much higher A02 values. A modification to the 
plasma was found to keep the pH down to about 7.7 - 7.8; some of 
the blood was removed before the addition of dextran. This blood 
sample was centrifuged hard, the leucocyte -free plasma being 
aspirated. The plasma was acidified. to pH 6.5 and a negative 
pressure applied to remove dissolved CO2. After about 30 
2ho ris 
minutes the pH was restored to 7.4 (method of MacLeod and Rhoda, 
1939). This treatment had little effect on the AO2 values. 
Fig. 7 shows the results of one experiment, demonstrating 
that the 'phosphate' Hanks medium is preferable to the other media. 
THE USE OF LARGE BLOOD VOLUMES 
In order to find the optimum conditions for the leucocyte 
respiration, it was necessary to increase the blood volume to have 
sufficient leucocytes for the comparison of two treatments. 400 mli. 
of whole blood were collected into siliconed blood bottles containing 
20 mis. of saline and preservative -free heparation in a final 
RECOVERY OF LEUKOCYTES DURING COLUMN SEPARATION 
22 22 
61 
20 f 20 
18 
16 ELUTING FLUID: 80%" HANKS" 
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1004 79.3 795 20.7 209 3630 pension 
B: 
- 10 49 23.5 1.5 0.2 76.5 47.5 22.7 760 20.9 
- 20 45.5 4.4 2.0 0.3 95.6 43.5 20.8 620 17.1 
- 30 26.5 1.9 0.5 0.1 98.1 26.0 12.4 480 13.2 
- 40 18.6 5.2 1.0 0.1 94.8 17.6 8.4 536 14.8 
- 50 14.2 5.6 0.8 0.1 94.4 13.4 6.4 520 14.3 
- 60 12.6 4.5 0.6 0.1 95.5 12.0 5.8 366 10.1 
- 70 9.3 8.0 0.8 0.1 92.0 8.6 4.1 260 7.2 
- 80 5.9 6.7 0.4 0.1 93.3 5.5 2.6 204 5.6 
- 90 - - - - - - - - - 
- 100 2.2 18.6 0.4 0.1 81.4 1.8 0.8 90 2.5 
- 110 - - - - - - - - - -- 
- 120 1.7 21.2 0.4 0.1 78.8 1.3 0.6 64 1.8 
- 130 - - - - - - - - - 
- 140 20.0 0.4 0.1 80.0 1.6 0.8 52 1.4 
150 - - - - - - - - - 
- 160 - - - - - - - - - 
- 170 1.5 24.1 0.4 0.1 75.9 1.1 0.5 34 0.9 
- 180 - - - - - - - - - 
- 190 - - - - - - - - - 
- 200 0.9 11.8 0.1 .40 88.2 0.8 0.4 20 0.6 
- 10 1.1 81.8 0.9 0.1 18.2 0.2 0.1 32 0.9 
- 20 2.1 62.0 1.3 0.2 38.0 0.8 0.4 16 0.4 
- 30 1.5 66.7 1.0 0.1 33.3 0.5 0.2 32 0.9 
- 40 1.8 75.0 1.4 0.2 25.0 0.5 0.2 6 0.2 
- 50 79.8 98.5 78.7 9.9 1.5 1.1 0.5 48 1.3 
- 60 150.0 99.3 149.0 18.7 0.7 1.0 0.5 100 2.8 
- 70 87.0 98.7 85.8 10.8 1.3 1,2 0.6 - - 
- 80 79.8 98.5 78.6 9.9 1.5 1.2 0.6 - - 
- 90 42.0 94.3 39.6 5.0 5.7 2,4 1.2 - - 
- 100 31.2 94.3 29.4 3.7 5.7 1.8 0.9 - - 
- 110 28.2 98.0 27.6 3.5 2.0 0.6 0.3 - _ 
- 120 14.4 100.0 14.4 1.8 0.0 0,0 0.0 - - 
- 130 - - - _ - - - - - 
- 140 9.5 88.5 8.4 1.1 11.5 1.1 0.5 12 0.3 
- 150 - - - - - - - - - 
- 160 - - - - - - - - - 
- 170 6.0 90.8 5.4 0.7 9.2 0.5 0.3 - _ 
- 180 - - - - - - - - - 
- 190 - - - - - - - - - 
- 200 2.9 91.4 2.7 0.3 8.6 0,3 0.1 _ - 
43. 
concentration of 10 U /ml. The erythrocytes were sedimented with 
1 volume of 5% dextran to 5 volumes of blood. The glass bead 
column was 2.5 cm x 35 cm. height. The volume of the leucocyte 
suspension applied to the column was approximately 45 mls. The 
volume of eluting fluids required to wash the leucocytes from the 
column was determined in one experiment by collecting 10 ml. 
aliquots of the effluent and determing the number of erythrocytes, 
PMN, and lymphocytes in each aliquot. The results of this 
experiment are given in table 14. A histogram (Fig. 8) shows the 
percentage of each cell type recovered in each aliquot. The 
overall differential counts were: 
i) lymphocyte eluate - 4.7% PMN : 95.3% lymphocytes, 
with 1 leucocyte : 21 erythrocytes; 
ii) PMN eluate - 97.3% PMN : 2.7% lymphocytes, 
with 1.9 leucocytes : 1 erythrocyte. 
The volume of eluting fluid required to obtain the lymphocytes 
was 200 mis . , while the volume for the PMN was 160 mis . 
This size of column was found to behave differently from the 
smaller columns. Previously the leucocyte suspension had been 
induced onto the column by a slight positive pressure. When 
using this procedure with the large column the leucocyte suspension 












a gentle negative pressure to the bottom of the column, taking about 
3 -4 minutes to fill the column. Using this procedure no clotting 
was ever observed. 
The oxygen uptake was measured over a two hour period, 
manometer readings being taken every 10 minutes. Fig. 9 shows 
the time course for the respiration of the two leucocyte suspensions. 
After about 30 minutes the rate of oxygen uptake became linear; 
consequently all determinations of the rate were made over the 
30 -90 minute time interval, giving seven points through which the 
line was drawn (in Fig. 9 there are only five points since readings 
were taken here every 15 minutes for 3 hours to show linearity 
over that time). The best line drawn through all the points 
including the 10 and 20 minute points did not always pass through 
the origin, for the following reason: the oxygen uptake at any time 
was calculated as the difference between the manometer readings 
at time zero and the readings at 10 minute intervals thereafter. 
Thus any error in the manometer reading at time zero was 
reflected in all the calculations of the oxygen uptake, with the 
result that the curve through all the points was displaced either up 
or down on the y -axis. However, this displacement did not effect 
the gradient of the line drawn through the 30 -90 minute time 
interval. Any error in reading the thermobarometer and control 
manometers at time zero also caused a shift of the curve relative 
45. 
to the y -axis. 
Since it had been observed that the use of 'phosphate' Hanks 
gave higher A02 values than normal Hanks, a few separations 
were tried using 'phosphate' Hanks to make up the dextran and the 
lymphocyte eluting fluid. This was found to be unsatisfactory, 
since both leucocyte suspensions were very contaminated with the 
other cell type. 
OXYGEN UPTAKE - THE EFFECT OF DIFFERENT CONDITIOI\S 
In an attempt to increase the ¿ O2's further, a number of 
experiments were conducted to test the effects of varying conditions 
on A02. 
1. The effect of 'phosphate' Hanks compared to normal Hanks. 
The separation and Warburg procedures were as indicated 
previously. The medium consisted of 50% plasma + 50% 
'phosphate' or normal Hanks. The results are given in table 15. 












±I.S.D. P* Value 
Mean 
tI.S.E. 
61 555 1029 
63 300 1044 
64 PMN 816 637.8 1142 1074.5 0.05 
65 880 +132.73 1083 + 25.22 
61 2703 2642 
63 lympho- 1634 1825 
64 cytes. 1889 2021.5 2606 2163.5 n.s.+ 
65 1860 + 234. 20 1581 + 270.60 
P determined using Students 't' test. + n. s . = not significant. 
46. 
There was a significant difference in PMN ¿02, the 'phosphate' 
Hanks medium giving the greater values. This medium also gave 
ee more consistent results. As far as the lymphocytes a-se concerned 
there is- no difference between the media. 
All further experiments were therefore conducted using a 
medium consisting of 50% plasma -F 50% 'phosphate' Hanks, pH 7.4. 
2. The effect of siliconed compared to unsiliconed Warburg flasks 
All glassware with which the blood was coming into contact 
was siliconed up to this point. It was thought possible that this 
coating might be having an adverse effect on the leucocyte 002. To 
test this idea two experiments were done using siliconed and 
unsiliconed Warburg flasks. The results are given in table 16. 
Table 16. The effect of siliconed and unsiliconed Warburg flasks 


































1621 + 102.45 
0.15 
* P determined using Students 't' test. 
There was a significant difference in PMN LSO , the siliconed 
2 
flasks giving the higher values. The lymphocytes were scarcely 
affected by the presence of silicone. 
3. The effect of additional calcium and magnesium 
Since EDTA, which was present in the PMN eluting fluid, 
chaelates divalent ions, it was feasible that the leucocytes, and in 
particular, the PMN, were lacking in these ions. Four 
experiments were therefore performed with double the normal 
calcium and magnesium concentrations. These results are shown 
in table 17. 
Table 17. THE EFFECT OF DOUBLED CALCIUM AND MAGNESIUM CONCENTRATIONS 
ON LEUCOCYTE CO2 
Expt. 
no. cell types 














































































































































































































































































































































































































































































































































































































































































There was little difference in PMN A02 with the two media, 
normal Cat+ and Mg ++ concentrations giving slightly higher values 
of 002. Lymphocytes, however, showed a greatly reduced rate 
of respiration when the Cat+ and .Mg ++ concentrations were 
increased. 
THE CORRECTION FACTOR IN LEUCOCYTE AO2 DUE 
TO ERYTHROCYTE CONTAMINATION. 
Up to this point the erythrocyte ¿O2 had been determined in 
all experiments to allow a correction factor to be applied for the 
erythrocyte contamination of the two leucocyte suspensions; in 
each determination of ¿02 flasks had been included which 
contained erythrocytes obtained from the dextran sediment with 
negligible leucocyte contamination. The erythrocyte concentration 
was adjusted to approximately that present in the lymphocyte 
suspension. Thus, knowing the erythrocyte ¿02 and also the 
erythrocyte contamination in the two leucocyte suspensions, the 
erythrocyte contribution to the oxygen uptake of the leucocyte 
suspensions was calculated. Table 18 shows the results of four 
experiments, the conditions being "phosphate" Hanks, normal Ca 
-F+ 
and Mg + +, and with the flasks being siliconed. The erythrocyte 
Loxygen uptake in the PMN flasks - 0.08% - is negligible, and even 






















































































































































































































































































































































































































































































































































































































































































































































































































erythrocytes Differential count ** 
x 106* x 10 
6 
* x 106* x 106* %PMN %L 
61 95.2 93.8 1.4 4.4 98.7 1.3 
62 88.4 83.4 5.0 24.0 94.4 5.6 
63 84.8 72.7 12.1 80.0 85.8 14.2 
64 78.7 69.7 9.0 25.6 88.6 11.4 
65 64.0 155.8 8.2 20.0 95.0 5.0 
66 77.2 69.1 8.1 0.4 89.5 10.5 
67 75.6 68.1 7.5 12.0 90.1 9.9 
68 92.0 78.9 13.1 16.0 85.8 14.2 
mean: 94.5 mean: 22.8 91.0 9.0 
S.E.: 1.64 1.64 
leucocyte :erythrocyte ratio = 94.5 22.8 
















Differential count ** 
%PMN %aL 
61 95.6 2.8 92.8 600 3.0 97.0 
62 72.4 13.3 59.1 1260 18.3 81.7 
63 71.0 5.9 65.1 630 8.3 91.7 
64 92.8 4.6 88.2 876 5.0 95.0 
65 94.8 5.2 89.6 860 5.5 94.5 
66 56.8 16.0 40.8 640 28.1 71.9 
67 118.0 17.0 101.0 800 14.5 85.5 
68 124.8 22.0 102.8 800 17.7 82.3 
mean : 90.7 mean : 808.25 mean: 







* Number of leucocytes per Warburg flask 
** Differential count expressed as % polymorphs ( %PMN) 



















































































































































































































































































































































































































































































































































































































































































It was therefore considered unnecessary in future work to 
make any allowance for the erythrocyte contamination of the 
leucocyte suspensions. 
THE EFFICIENCY OF THE COLUMN SEPARATION 
OF LEUCOCYTES 
The efficiency of the column separation procedure in this 
series of experiments is summarised in tables 19 and 20. Table 
19 shows the yields of the leucocytes, 33.4% of the PMN and 46.5% 
of the lymphocytes being recovered from the number added to the 
column. Table 20 shows the contamination of the suspensions with 
the other leucocyte type, the average differential counts being: 
for the PMN suspension 91.0% PMN : 9.0% lymphocytes, 
and 
for the lymphocyte suspension 12.6% PMN : 87.4% lymphocytes. 
A comparison of the efficiencies of the separations using 
different column sizes is shown in table 21. There appear to be 
trends, though these are not great, for 
i) the yields of both PMN and lymphocytes to decrease as 
the column size increases, and 
ii) for the purity of the two leucocyte suspensions to decrease 
as the column size increases. 
50. 
CONDITIONS FOR SEPARATION AND DETERMINATION OF OXYGEN 
UPTAKE OF LEUCOCYTES TO BE OBSERVED IN FUTURE WORK. 
The separation procedure seemed to be working 
satisfactorily at this stage. Although the values for A02 were low 
they were reasonably constant. Since there did not seem to be any 
obvious modifications for either the separation or oxygen uptake 
measurements, a study of the effects of drugs on leucocyte 
respiration was begun. The conditions adhered to were: 
1) for the separation procedure: 
i) the erythrocytes were sedimented with Pharmacia 
dextran 250 in Hanks solution at pH 7.4; 
ii) all centrifugation was carried out at less than 150G. 
iii) leucocyte suspensions were added to the column using 
a gentle negative pressure, taking 3 -4 minutes to fill 
the column; 
iv) the lymphocyte eluting fluid was 80% Hanks + 20% plasma, 
the volume being about 200 mis . ; 
v) the PMN eluting fluid was 0.02% EDTA, the volume being 
about 160 -180 mis. Plasma was added to the collecting 
tubes, the final concentration being 20%; 
51. 
vi) the separated leucocyte suspensions were made to the 
required volume with 'neutralised' plasma. 
2. for the oxygen uptake determinations: 
i) all flasks were siliconed; 
ii) air was used as the gas phase; 
iii the medium was 50% plasma + 50% 'phosphate' Hanks) P4 
iv) KOH was placed on filter paper in the flask side -arm; 
v) no erythrocyte suspensions were included; 
vi) the flasks were shaken in the water bath at 120 -130 
oscillations per minute; 
vii) the rate of oxygen uptake was determined over the 
30 -90 minute period. 
SUMMARY OF 'NO -DRUG' RESULTS. 
When the effects of drugs on leucocyte respiration were being 
investigated, the procedure was to divide the separated leucocyte 
suspensions into two parts; the drug was added to one half, the 
other half being used as a 'no -drug' control. Consequently, over 
a period of time the number of 'no -drug' results accumulated. 
Taking these results together it was possible to obtain some 
reasonably accurate averages for the efficiency of the separation 
procedure, and also for the PMN and lymphocyte .6O2's. 












Total no. of 
leucocytes in the 
leucocyte suspension 
x 106 





%PMN* %L* %PMN* %L* 
87 - - - - 3010 1720 57.2 
88 70.0 30.0 66.3 33.7 2590 1850 71.5 
89 63.3 36.7 67.7 32.3 2810 1390 49.5 
90 59.3 40.7 60.0 40.0 2980 1420 47.7 
91 61.8 38.2 67.6 32.4 2880 1568 54.4 
92 72.0 28.0 68.0 32.0 2805 1462 52.2 
93 - - - - 3315 2230 67.3 
94 67.4 32.6 68.3 31.7 3620 2240 61.8 
95 - - - - 3455 2555 73.9 
96 68.2 41.8 58.5 41.5 2290 1236 54.1 
97 71.0 29.0 72.3 27.7 1138 904 79.5 
98 70.2 29.8 75.8 24.2 3450 2620 76.0 
100 60.6 39.4 60.5 39.5 2158 1610 74.8 
101 61.3 37.8 63.5 36.5 3020 1280 42.4 
102 65.0 35.0 70.2 29.8 2860 1860 65.3 
103 68.2 41.8 63.0 37.0 2510 1099 43.8 
104 64.5 35.5 65.6 34.4 3160 2024 64.2 
105a 59.8 40.2 71.2 28.8 2010 1425 70.8 
106a 66.7 33.7 78.8 21.2 2 110 1738 82.4 
105b 61.0 39.0 65.8 34,2 4070 2120 52.1 
106b 55.0 45.0 64.6 35.4 3185 1650 51.8 
108 59.6 40.4 62.3 37.7 1468 1125 76.8 
109 76.3 23.7 68.8 31.1 3465 2416 69.7 
110 68.8 31.2 76.5 23.5 2468 1250 1..;'"7 6877- 
113 61.0 39.0 63.0 37.0 2830 1788 63.3 
114 64.6 35.4 67.3 32.7 1210 975 80.6 
115 64.2 35.8 73.5 26.5 4020 3190 79.5 
116 68.0 32.0 78.3 21.7 2890 2210 76.5 
117 63.9 3711 64.6 35.4 1550 862 55.5 
118 70.4 29.6 67.8 32.2 1812 1555 85.8 
119 65.2 34.8 65.3 34.7 - - - 
120 64.8 35.2 69.9 30.1 2250 1638 72.8 
121 67.0 33.0 68.7 31.3 3457 31,`75 2730 78.6 
122 59.1 40.9 69.2 30.8 2375 1440 60.7 
123 72.4 27.6 77.3 22.7 3333 1662 49.8 
124 75.0 25.0 77.5 22,5 2670 1647 61.7 
125 70.2 29.5 68.2 31.8 2275 915 -40.3 
126 59.7 40.3 65.4 34.6 2693 1382 51.4 
127 71.9 28.1 64.4 36.6 1444 708 49.2 
128 72.4 27.6 75.3 24.7 2220 1179 53.2 
129 56.3 43.7 70.6 29.4 1952 1310 67.3 
130 61.2 38.8 67.2 32.8 2015 1480 73.5 
Mean 65.06 34.94 68.44 31.56 6/.18 
* %PMN = % polymorphs 
atr - 0/-i....,.,1,n....+nc 
52. 
1. Yield of leucocytes following dextran sedimentation 
Dextran sedimentation not only reduced the number of 
erythrocytes, but also reduced the number of leucocytes: 
1) Table 22 shows a) the total number of leucocytes in 
whole blood, 
b) the total number of leucocytes in the 
leucocyte suspension after dextran 
sedimentation, and 
c) the percentage yield of leucocytes after 
dextran sedimentation. 
It can be seen that only 62.2% of the leucocytes were 
recovered. This is the recovery which would be expected. 
Initially the erythrocytes and leucocytes are distributed uniformly 
throughout the blood sample. After dextran sedimentation the 
volume of the sedimented erythrocytes is about one third of the 
total volume. Assuming no leucocytes sediment, one would 
expect to recover about 66% of the leucocytes from the erythrocyte - 
poor supernatant. 
11) Table 22 also shows a) the differential count of whole bloo 
and 
b) the differential count of the 
leucocyte suspension. 
The mean differential count changed from 65.1% PMN : 
34.9% lymphocytes to 68.4% PMN : 31.6% lymphocytes, i.e. there 

















































% leucocytes recovered from Differential counts of the leucocyte suspension* 
Whole blood Column Polymorph suspension Lymphocyte = suspension 
PMN L PMN %PMN %L %I IN `AL 
A B C D E F G H 
- - 28.1 48.8 93.8 6.2 4.1 95.9 
- - 21.8 35.0 83.4 16.6 9.0 91.0 
15.0 44.5 22.1 55.3 92.8 7.2 7.3 92.8 
12.0 20.1 22.7 45.0 94.0 6.0 10.8 89.2 
22.4 25.2 46.5 54.0 88.9 11.1 8.6 91.4 
21.2 35.1 35.9 63.7 92.6 7.4 5.5 94.5 
37.8 35.1 76.8 59.3 91.0 9.0 12.5 87.5 
28.0 25.7 32.2 59.8 92.5 7.5 8.3 91.7 
37.9 51.0 60.5 60.2 91.8 8.2 9.1 90.9 
- - 21.0 66.0 92.2 7.8 13.4 86.6 
18.8 34.0 34.6 63.5 90.3 9.7 6.8 93.2 
42.8 40.8 53.0 53.6 91.5 8.5 6.3 93.7 
31.7 39.9 38.7 65.0 92.9 7.1 13.4 86.6 
33.0 40.4 45.2 54.0 90.0 10.0 9.6 90.4 
35.1 30.4 79.8 77.8 91.5 8.5 5.6 94.4 
18.8 29.5 26.7 52.9 91.2 8.8 8.2 91.8 
30.1 18.8 64.3 47.3 92.8 7.2 6.4 93.4 
22.5 29.8 32.1 54.2 90.3 9.7 4.2 95.8 
22.9 17.5 23.5 33.4 94.3 5.7 8.0 92.0 
40.7 38.1 48.3 74.8 12.8 87.2 
27.4 31.7 49.8 69.2 90.2 9.8 6.5 93.5 
31.3 28.8 51.3 70.2 96.4 3.6 4.4 95.6 
31.7 58.2 39.5 81.7 92.9 7.1 7.4 92.6 
37.9 57.2 60.0 62.7 94.6 5.4 3.0 97.0 
23.1 24.2 41.0 63.5 89.8 10.2 11.0 89.0 
26.4 28.8 40.5 47.8 91.2 8.8 8.0 92.0 
28.2 44.8 33.7 60.2 93.5 6.5 5.2 94.8 
36.6 . .  44 0 40 2 74.8 95.0 5.0 8.5 91.5 
56.0 29.8 63.0 58.0 95.9 4.1 7.5 92.5 
24.4 38.7 43.4 70.9 92.9 7.1 5.7 94.3 
40.1 42.4 48.4 45.7 94.9 5.1 7.1 92.9 
29.9 34.2 48.8 55.9 97.0 3.0 4.5 95.5 
41.5 27.5 52.9 43.8 96.7 3.3 8.5 91.5 
62.0 50.7 77.2 67.8 93.5 6.5 10.0 90.0 
47.7 41.2 67.2 89.7 95.0 5.0 6.0 94.0 
16.6 19.4 19.8 47.5 94.5 5.5 6.7 93.3. 
37.8 73.2 63.6 84.7 93.9 6.1 9.2 90.8 
24.9 36.3 34.1 59.3 95.2 4.8 15.1 84.9 
19.2 26.3 43.1 59.3 94.7 5.3 6.3 93.7 
18.9 47.7 43.1 76.8 96.3 3.7 7.8 92.2 
16.4 27.7 29.8 58.0 95.7 4.3 4.9 85.1 
30.3 25.3 36.0 55.8 93.8 6.2 6.5 93.5 
22.5 32.1 27.5 51.7 97.3 2.7 4.5 95.5 
Mean,: 29.9 35.5 43.8 60.3 93.1 6.9 8.8 91.2 
S.E.: 1.77 1.87 2.47 1.99 0.40 0.40 0.69 0.69 





100 leukocytes * 
(65.l%PMN:34.1% lymphocytes) 
...65.1PMN +34.1 lymphocytes 
t 




(68.4%,PMN: 31.6% lymphocytes) 
...43.OPMN + 20.2 lymphocytes 
+ 100 -300 
erythrocytes 
PMN suspension Lymphocyte suspension 
19.1 leukocytes 
(93.1% PMN: 6.9% lymphocytes) 
. .17.8 PMN + 1.3 lymphocytes 
+ 5 erythrocytes 
12.5 leukocytes 
(8.8% PMN: 91.2% lymphocytes) 
1.1 PUN + 11.4 lymphocytes 
+ 120 erythrocytes 
*for convenience, the initial total number of leukocytes is taken as 100 
Fig. 10. GENERAL SCHEME OF GLASS BEAD SEPARATION PROCESS 
TABLE 24. THE OXYGEN UPTAKE OF SEPARATED POLYMORPHS AND LYMPHOCYTES. 
Experiment 
number. 





















































































































PMN : 6.9% lymphocytes. This was more contamination than 
was found by Rabinowitz, (99.99% PMN), but he used a greater 
lymphocyte eluting volume which should have removed more of 
the lymphocytes. 
Columns G and H show the average PMN contamination of 
the lymphocyte suspension, the differential count being 8.8% 
PMN : 91.2% lymphocytes. (Rabinowitz found 2.1% : 97.7%, 
and Hedeskov and Esmann 1.7% : 98.3% respectively. 
The results in tables 22 and 23 are summarised in Fig. 10. 
4. The oxygen uptake of PMN and lymphocytes 
Table 24 shows the results of 36 control determinations of 
the two AO2's, their mean values being 
A02 PMN = 1488 ) 
10 )µL/hour X10 leucocytes. 
0 02 lymphocyte = 2726 ) 
These values are somewhat lower than those obtained by 
Rabinowitz (3600 and 4100), and by Hedeskov and Esmann 
(2618 and 2618). 
It was stated previously that the rate of oxygen uptake was 
estimated over the 30 -90 minute interval. If the rate is 
estimated over the 0 -60 or 0 -120 minute interval somewhat 
different AO2's are obtained as is indicated in Fig. 10a_ Table 25 
J 
MIN UTES 






Rate of oxygen uptake measured over 
different time intervals. 
We 25. THE OXYGEN UPTAKE OF POLYMORPHS AND LYMPHOCYTES CALCULATED OVER DIFFERENT TIME INTERVALS 
Oxygen uptake in LWhour /10 
1 
0 leucocytes calculated over the 
time interval 
Experiment 
number Polymorphs L mhocytes 
O - 60 rains. O - 60 mins. 0 - 120 mins. 0 - 120 mins. 
88 2119 1560 4535 3430 
89 4390 3055 6090 4970 
93 1595 1267 3940 3245 
95 3390 2865 3155 3170 
98 1490 1058 3800 3030 
103 3065 2200 4065 34Q5 
105 3575 2500 4265 3155 
106 2000 1710 3390 2900 
107 2605 2050 3930 2995 
108 2505 3130 4280 2918 
109 2408 1998 3982 2840 
112 2383 1733 4600 3330 
114 5140 3860 4340 3360 
115 3885 2670 3770 3050 
116 2050 1620 5410 4260 
117 2070 1940 1930 2025 
118 2880 2170 6020 4910 
119 2805 2475 4485 3750 
120 3030 2275 6100 4470 
121 2505 1787 3990 2870 
122 2940 2333 5480 4110 
123 1574 1417 3315 3000 
124 2776 2130 5985 4630 
125 1985 1790 3450 3205 
126a 4640 3692 4130 3400 
126b 2952 2255 3330 3025 
127 3630 2730 4150 3245 
128 4340 3220 6320 4635 
129 4400 2940 5550 4110 
130 6480 4240 8580 6150 
3053.5 2355.6 4545.6 3587.1 mean: 
55.JSL iSI 
shows the AO2 values calculated over these time intervals 
(uncorrected for contamination with the other leucocyte type), 
t he mean values being: 
0 -60 minutes : 002 PMN = 3053 ) 
: A02 lymphocytes = 4546 ) 
µ I,/hour/1010 
0 -120 minutes : 002 PMN = 2356 
002 lymphocytes = 3587 
leucocytes 
Thus one possible explanation for the discrepancy between 
these results and those obtained by Rabinowitz, and by Hedeskov 
and Esmann, is that the rate of oxygen uptake was estimated over 
different time intervals. Neither of these workers states over 
which time interval their measurements were made, Rabinowitz 
stating that "measurements of oxygen uptake were made for at 
least two hours ", while Hedeskov and Esmann say that the 
rate of oxygen uptake is linear for at least four hours. 
58. 
5. Leucocyte crowding 
It was mentioned previously(page Iq)that prior to the 
separation procedure being attempted a number of experiments 
were done to see whether A02 was influenced by the number of 
leucocytes per Warburg flask. In those determinations of A02, 
no observable crowding was noticed, but this may have been due 
to the limited number of results. 
The crowding effect has been observed by a number of 
workers. Barron and Harrop (1929) when determining AO2 for 
leukaemic leucocytes found the crowding to be more marked for 
lymphocytes than for PMN. Hartman (1952) noticed crowding 
when estimating the L O2 of guinea pig exudate PMN in a buffered 
serum medium; in a buffered saline medium very little 
crowding was apparent. Esmann (1964) however, found crowding 
in a suspension consisting mainly of PMN (human) when 
estimating oxygen uptake, lactic acid production, and glucose 
uptake in a buffered serum -free medium. Hedeskov and Esmann 
(1966) using column separated lymphocytes found a crowding effect 
which was particularly noticeable at lymphocyte concentrations 
6 
below 15 x 10 /ml. They found a linear relation between log10 
(number of lymphocytes per ml.) and the corresponding log10EO2. 











INFLUENCE OF POLYMORPH 
CONCENTRATION ON 0O2 
e 
(CORRELATION COEFFICIENT : r = -0.295 
MC SIG. at p =0I ) 
75 7.6 7.7 7.8 7.9 8.0 8.1 8.2 
LOGIO PMN CONC" 
Figure 11. 















86 70.0 7.8451 1163 3.0656 
87 42.5 7.6284 844 2.9263 
88 54.7 7.7380 857 2.9330 
89 42.6 7.6294 1477 3.1694 
90 80.8 7.9074 1018 3.0076 
91 74.5 7.8722 1644 3.2158 
92 155.9 8.1928 705 2.8482 
93 101.6 8.0068 1394 3.1443 
95 70.8 7.8500 2084 3.3189 
96 51.6 7.7126 2566 3.4092 
98 147.6 8.1691 1356 3.1322 
99 120.8 8.0820 860 2.9345 
100 70.2 7.8463 1342 3.1277 
101 48.4 7.6848 1568 3.1955 
102 55.2 7.7419 1777 3.2497 
103 61.3 7.7875 1071 3.0298 
104 55.0 7.7404 1592 3.2034 
105a 52.0 7.7160 1202 3.0806 
105b 68.0 7.8325 1438 3.1577 
106 52.6 7.7210 1254 3.0983 
107 63.0 7.7993 1134 3.0697 
108 51.8 7.7143 1716 3.2345 
109 85.2 7.9304 1490 3.1732 
110 63.0 7.7993 1484 3.1715 
112 135.8 8.1329 1000 3.0000 
113 66.8 7.8248 2229 3.3481 
114 45.4 7.6571 2357 3.3724 
115 78.3 7.8938 1839 3.2646 
116 90.9 7.9586 1091 3.0378 
117 44.8 7.6513 1965 3.2934 
118 86.9 7.9390 1270 3.1038 
119 82.0 7.9138 2072 3.2160 
120 81.4 7.9104 1209 3.0823 
121 120.3 8.0802 1277 3.1062 
122 95.2 7.9786 1613 3.2076 
123 60.8 7.7059 1153 3.0618 
124 108.0 8.0334 1457 3.1635 
125 81.7 7.9122 1454 3.1626 
126a 60.4 7.7810 1643 3.2156 
127 41.4 7.6170 1747 3.2422 
128 51.8 7.7143 2186 3.3397 
126b 49.6 7.6955 2682 3.4284 
129 103.0 8.0128 1602 3.2046 
3.6- 
3.2- 
INFLUENCE OF LYMPHOCYTE 







( CORRELATION COEFFICIENT : r= -0.15 
NOT SIG. at p =OI ) 
I I I I 
I I I I 
7.4 7.5 7.6 7.7 7.8 7.9 8.0 8.1 
LOGIO LYMPHOCYTE CONC" 
Figure 12. 
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86 97,8 7.9903 2520 3.4014 
87 46.5 7.6675 2485 3.3954 
88 69.7 7.8432 2257 3.3535 
89 41.8 7,6212 3597 3.5559 
90 61.8 7.7910 3116 3.4936 
91 63.5 7.8028 3175 3.5018 
92 54.5 7.7364 3936 3.5951 
93 77.7 7.8904 2485 3.3954 
95 98.4 7.9930 2750 3. 'WV, 
96 59.2 7.7723 2613 3.4171 
98 77.6 7.8899 2193 3.3410 
99 76.8 7.8854 2606 3.4160 
100 70.0 7.8451 2801 3.4474 
101 69.6 7.8426 2204 3.3432 
102 60.2 7.7796 2946 3.4692 
103 39.4 7.5955 2690 3.4298 
104 80.2 7.9042 2481 3.3945 
105a 63.4 7.8021 2492 3.3966 
105b 96.8 7.9859 2989 3.4755 
106 91.4 7.9609 2524 3.4021 
107 48.4 7.6848 2341 3.3694 
108 67.2 7.8274 2273 3.3566 
109 91.6 7.9619 2301 3.3619 
110 27.4 7.4378 3079 3.4884 
112 63.0 7.7993 3098 3.4911 
113 60.5 7.7818 2009 3.3029 
114 39.6 7.5977 2797 3.4467 
115 124.6 8.0955 2453 3.3897 
116 54.5 7.7364 3282 3.5162 
117 42.5 7.6284 2331 3.3676 
118 44.8 7.6513 3967 3.5985 
119 68.0 7.8325 3256 3.5127 
120 41.0 7.6128 3327 3.5220 
121 111.6 8.0476 1937 3.2871 
122 76,7 7.8848 2777 3.4463 
123 36.2 7.5587 2822 3.4505 
124 51.8 7.7143 3375 3.5283 
125 4844 7.6848 2778 3.4438 
126 50.2 7.7007 1999 3.3009 
127 37.6 7,5752 2298 3.3613 
128 32.6 7.5132 2834 3.4524 
129 45.0 7.6531 2829 3.4516 
130 40.0 7.6021 2574 3.4106 
59. 
experiments using the results from 43 'no -drug' experiments. 
Tables 26 and 27 show the number of leucocytes per Warburg flask, 
the corresponding AO2's, and their logs. Figs. 11 and 12 are the 
graphs of log10 (number of PMN /lymphocytes per flask) vs. 
(of the corresponding AO2). The best straight lines were 
calculated. 
i) For PMN : equation of the line was 
Y = -O. 256X -F 5.166, 
with a correlation coefficient of r = -0.295 which is 
significant at p = 0.1 (at p = 0.1, r = 0.2542). 
log10 
This result cannot be compared with other results since none are 
available for separated PMN. The nearest experiments are those 
of Esmann (1964) who used a suspension consisting mainly (85%) 
6 
of human PMN with a concentration range of 8 -40 x 10 /ml. In 
the present work the calculations of the crowding effect were on 
the basis of the number of leucocytes per Warburg flask, i.e. per 
4.0 mls. Thus the equivalent leucocyte concentration used by 
Esmann was 32 -160 x 106/4.0 mls. which is a similar range to 
that used in these experiments. On a semi -log graph Esmann 
obtained a linear relation between AO and the leucocyte 
concentration with r = -0.44 which is significant at p < 0.001. 
However in the later paper by Hedeskov and Esmann (1966) it is 
60. 
stated that a log -log graph gives a linear relation between AO2 and 
leucocyte concentration. It is thus questionable whether Esmann's 
value for the correlation coefficient of PMN crowding of -0.44 is 
valid. 
ii) For lymphocytes : equation of the line was 
Y = -0.0738X + 4.004 
with r = -0.152 which is not significant (at p = o.l, r = t. 2542) 
Hedeskov and Esmann using separated lymphocytes found 
significant crowding (r = -0.91, p < 0.001) which does not agree 
with the result presented here (p > 0.1) the difference being 
difficult to explain. The cause of the crowding effect is not known. 
It has been demonstrated that it is not due to variation in pH, lack 
of glucose or organic phosphate, nor to accumulation of lactic 
acid ( Esmann 1962). 
Since it has been shown that the oxygen uptake is linear with 
time after the first 30 minutes (Hedeskov and Esmann 1966, this 
work) it is unlikely that accumulation of an inhibitor is responsible, 
The viscosity of blood increases at leucocyte concentrations above 
40 x 10 
6 /ml. (Stephens 1936) this being readily apparent above 
about 60 -70 x 106 /ml. Since the rate of diffusion of gas through 
a liquid is inversely related to the viscosity of the liquid, high 
leucocyte concentrations would be expected to decrease the rate 
of 02 diffusion through the medium. 
SECTION 3. THE DETERMINATION OF THE LACTIC ACID 
PRODUCTION OF SEPARATED LEUCOCYTES 
61. 
INTRODUCTION 
A number of methods for the determination of lactic acid 
(LA) in blood have been developed. These include chemical and 
biochemical methods: 
1. The chemical estimation of LA 
i) Friedemann and Graeser (1933) oxidised the LA to yield an 
acetaldehyde bisulphite compound. The bisulphite was titrated 
against a dilute iodine solution and the amount of acetaldehyde 
calculated, the acetaldehyde concentration being proportional to the 
original LA concentration. 
ii) Barker and Summer son (1941) oxidised the LA to 
acetaldehyde and obtained a coloured compound on addition of 
p- hydroxydiphenyl. Modifications of this method to limit the 
interference by impurities were made by Hullin and Noble (1953), and 
Mitchell and Coui and (1955). 
iii) In Scholander and Bradstreet's (1962) micro method 
semicarbazide was used to give a colour after the LA was 
oxidised. 
iv) Gas chromatography (Hoffman et a11964) has also been 
used to estimate oxidised LA, this being a very sensitive method. 
2. Biochemical estimation of lactic acid 
i) Lundholm et al (1963a) reduced lactate with lactate 
62. 
dehydrogenase in the presence of NAD to give pyruvate and NADH. 
The rate of loss of NAD, which was directly proportional to the rate 
of lactate --* pyruvate, was followed in a dual-beamspectrophoto- 
meter. This method is specific for L (-f) lactic acid. 
Lundholm et al (1963b) compared the various methods for 
estimating lactic acid and concluded that: 
a) the biochemical method was the most sensitive and the most 
specific, 
b) the method of Friedemann and Graeser was generally 
inferior to the biochemical method; 
c) Barker and Summerson's method was liable to 
methodological errors. 
It was decided to use the method of Barker and Summerson 
since many workers have used this method apparently successfully, 
and the enzymatic method appeared somewhat complex. 
THE METHOD OF BARKER AND SUMMERSON. 
1. The principles of the method 
The basis of the method is as follows: 
i) precipitation and removal of protein; 
ii) treatment with copper sulphate and calcium hydroxide to 
remove substances which interfere with the colour 
reaction, e.g. glucose, dihydroxyacetone, glyceraldehyde, 
63. 
p- hydroxyphenylactic acid, malic acid, pyruvic acid, 
and rhamnose (Van Slyke, 1917). 
iii) oxidation of lactic acid to acetaldehyde with sulphuric 
acid; 
iv) addition of p- hydroxydiphenyl to give a purple colour. 
2. Materials 
10% trichloracetic acid (TCA)a. 
4% copper sulphate .12 H2O solution (CuSO4)a. 
20% copper sulphate. 12 H2O solution (CuSO4)a. 
Powdered calcium hydroxide (Ca(OH)2) b. 
Concentrated sulphuric acid, sp. gr. 1.84 (H2SO4)c. 
1.5% p- hydroxydiphenyld(PP) in 0.5% sodium hydroxidea. 
Potassium lactatee - 50% in water. 
Zinc nitrate f. . 
All solutions were made up in distilled water. 
The purple colour was read in 
a) Unicam SP 1300 colourimeter, using a No. 4 filter with 
band width 510 -590 m(.. 
b) Unicam SP 500 spectrophotometer, wavelength 
560 mµ in 1 cm light path glass cuvettes. 
All pipettes were of the delivery type. 
64. 
The sulphuric acid was delivered from a burette, the 
stopcock being lubricated with the acid. 
Where 'tubes' are mentioned, these were 10 ml. graduated, 
stoppered Exelo tubes of 15 ml. total capacity. 
a - A n a lar grade, 
b - Extra pure grade, 
c - Microanalytical reagent, 
d - Spot -test reagent, 
e - Laboratory reagent, 
f - Laboratory chemical, 




May and Baker. 
i) After the two hour incubation period in the Warburg flasks, 
when the oxygen uptake was being measured, the /flask contents 
were pooled. 3.0 mls. were removed and added to 2.0 mis. 10/0 
TCA in 15 ml. stoppered tubes. The tubes were shaken well and 
stood for 10 minutes. The precipitated protein was removed by 
centrifugation at 4000 rpm for 10 minutes in an MSE Minor 
swinging -arm centrifuge. 
ii) 2.0 mis. of the protein -free supernatant were added to 
7.0 mis . water and 1.0 ml. of 20% CuSO4; approximately 1 gm of 
65. 
Ca (OH)2 was added and the tubes shaken. After 30 minutes 
standing with occasional shaking the blue precipitate was 
removed by centrifugation as above. 
iii) 1.0 ml. of the resulting supernatant was added to a fresh 
tube taking care to exclude the surface film precipitate. 0.05 mls. 
of 2.0% CuSO4 were added followed by 6.0 mls. of H2SO4. In 
order to keep the temperature down to less than 70°C the addition 
of the H2SO4 was carried out in an ice bath. The tubes were then 
placed in a boiling water -bath for 5 minutes to complete the 
reaction LA acetaldehyde, after - which they were cooled to 
20 
o 
C in cold water. 
iv) 0.1 ml. p- hydroxydiphenyl then added, the 
resulting precipitate being dispersed by shaking. The colour was 
allowed to develop for 30 minutes at 30°C, the tubes being shaken 
every 10 minutes. At the end of this period the excess PP was 
dissolved by heating the tubes in a water -bath at 100°C for 90 
seconds, followed by cooling to room temperature in cold water. 
v.) The colour intensity was read as the % transmission with 
reference to a blank which had been through the whole procedure, 
distilled water being added instead of the cell suspension. On the 
SP 500 and SP 1300 spectrophotometers the % transmission (%T) 
3.0 mis of cell suspension from the Warburg flasks, + 2.0 ml. 10% TCA 
centrifuge 
precipitate discarded 




1.0 ml. supernatant + 0.05 ml. 4.0% CuSO4 + 6.0 ml. F-i2SO4. 
r 
Heat at 100 C for 5 minutes then cool 
add 0.1 ml. PP. 
Stand at 30 
o 
C for 30 minutes, then place in a boiling water -bath for 
90 seconds. 
Read purple colour in SP 500 or SP 1300, at 560 mµ. 
Fig. 13. GENERAL SCHEME OF THE METHOD OF BARKER AND SUMMERSON, 
66 i7 
and optical density (OD) could both be read off directly. However 
the %T was always read since this was a linear scale so the reading 
of the value of the %T should have been subject to a constant error. 
The OD was on a log. scale so the greater the OD the greater the 
error in reading its value. The %T was readily converted to OD 
by applying the equation 
OD = 2 - log10 T. 
The method is summarised in Fig. 13. 
68. 
THE STANDARD LACTIC ACID CURVE 
1. The lactic acid standard 
In order to estimate unknown samples of LA. a standard curve 
was determined. The LA standard solution was made according to 
the method of Lundholm et al. (1963b) : 60 mis. of 50% potassium 
lactate were added to 30 gms. of zinc lactate and mixed well. On 
standing, a thick white precipitate formed which was filtered off and 
recrystallised twice from water. The resulting powder was dried 
for 24 hours at 100oC in an oven, and for 24 hours in a dessicator 
over phosphoric oxide. According to Lundholm et al this powder 
consisted of 99.6% zinc lactate. A melting point determination 
was not done because no information about its melting point could 
be found for this compound. 
297.57 gm zinc lactate 3H2Oa -,.180.16 gm. LA . 
0.1651 gm zinc lactate in 100 mis -k a solution containing 
1000N.gLA /ml. 
This solution was used as the stock LA solution, various 
dilutions being made. 
2. The standard curve 
According to Barker and Summerson., the graph of OD v. 
µ.g LA is a straight line over the range 0 -12 p.g LA. Two 
experiments were done to check the linearity of the line. For 
a Formula from Handbook of Chemistry and Physics, (1949). 
Chemical Rubber Publishing Co. Ltd., Cleveland, Ohio. 
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FIG.19 THE STANDARD CURVE 
Figures 14, 15, 16, 17, 18, 19. 







Test 2 Mean 
100 
75 
Colour too intense to measure. 
50 1.7 1.7 1.7 
25 1.08 1.10 1.09 
10 0.535 0.523 0.529 
7.5 0.458 0.475 0.4665 
5.0 0.318 0.319 0.3185 
2.5 0.192 0.177 0.1845 
1.0 0.o68 0.078 0.073 
0.75 0.069 0.086 0.0775 
0.50 0.055 0.03] 0.043 
























































































































































































































































































































































































































































































































































































































































































































































































































this purpose only the final colour reaction procedure was used 
(stages iii) and iv) of the method). The lactic acid concentrations 
used were 0 -100 µg /tube (µg LA/ tube refers to the total amount of 
LA in the tube at stage iii of the method onwards, the solution 
volume being 7.15 mls.) The results are shown in table 28 and 
fig. 14. It will be observed that the line is not linear over the 
ranges 0 -10 and 0 -50 1.1.g LA /tube. 
There were two obvious possibilities for the occurrence of 
this curve: 
i) the incubation time during the reaction LA -> acetaldehyde 
was incorrect, or 
ii) the CuSO4 - Ca(OH)2 treatment is required. 
3. The effect of time on the LA -i acetaldeh de reaction with the 
CutSOi4 - Ca(OH)2 treatment included 
It was possible that the LA --> acetaldehyde reaction was not 
continuing to completion particularly at the higher LA 
concentrations. An experiment was done to check this using three 
LA concentrations (2, 6, 10 µg LA /tube) with four incubation 
periods (2, 5, 7.5, 10 minutes). The CuSO4 - Ca(OH)2 
treatment was also included. Table 29 shows the OD values at the 
various LA concentrations, while Fig. 15 shows the graph of OD 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In all cases a curve was obtained, very similar curves being 
found for incubation times of 2, 5, and 7.5 minutes. It was 
therefore concluded that the LA -> acetaldehyde reaction was 
continuing to completion, and that the CuSO4 - Ca(OH)2 treatment 
was not exerting a significant effect towards making the line linear. 
4. Unicam SP 1200 or SP 500 for colour measurement? 
Another possibility for the occurrence of the curve was that 
the SP 1300 spectrophotometer, which had been used up to this 
stage, was not sufficiently sensitive or that the band width was too 
wide (510 - 590 mil). An experiment was therefore performed with 
0 -10 µg LA Í tube with no CuSO4 - Ca (OH)2 treatment and measurin 
the %T on the SP 1200 and also on the SP 500. The results are 
shown in table 30 and Fig. 16. As usual the SP 1300 gave a 
curve, while the SP 500 gave a straight line over the range 0 -8 
µg LA / tube, the line then apparently falling off. 
To determine whether this falling off of the line was 
experimental error or fact, two experiments were done over the 
range 0 -30 Fig LA / tube with no CuSO4 - Ca (OH)2 treatment, the 
colour being measured in the SP 500. The results are shown in 
table 31 and Fig. 17. Once again the graph shows a curve. 
Table 32. LACTIC ACID CONCENTRATION AND OPICAL DENSITY - EFFECT OF 




% Transmission (%T) 
Log10 T Optical density 
Test 1 Test 2 Mean 
5 50.2 51.6 50.9 1.7067 0.2933 
10 25.6 25.8 25.7 1.4099 0.5901 
15 14.0 14.4 14.2 1.1523 0.8477 
20 7.2 7.4 7.3 0.8633 L.1367 
25 3.8 4.2 4.0 0.6021 1.3979 
30 1.9 2.0 1.95 0.2900 1.7100 
Table 33. LACTIC ACID CONCENTRATION AND OPTICAL DENSITY 




Test 1 Test 2 Test 3 Mean 
%T* 
Mean 
OD+ %T* OD+ %T* OD+ %T* OD* 
1 83.1 0.0804 82.4 0.0841 85.8 0.0665 83.77 0.0769 
2 69.4 0.1586 73.8 0.1319 72.0 0.1427 70.07 0.1506 
3 56.0 0.2518 56.2 0.2503 57.6 0.2396 56.60 0.2472 
4 47.5 0.3233 48.8 0.3116 50.7 0.2949 49.00 0.3098 
5 42.4 0.3546 42.0 0.3969 42.2 0.3747 42.20 0.3750 
6 33.2 0.4789 32.6 0.4868 35.0 0.4559 33.60 0.4737 
7 28.4 0.5467 27.9 0.5544 29.6 0.5287 28.63 0.5431 
8 24.9 0.6038 25.0 0.6021 24.6 0.6091 24.83 0.6050 
9 21.5 0.6676 19.1 0.7190 - - 20.30 0.6925 
10 17.3 1 0.7610 17.3 0.7610 17.4 0.7595 17.33 0.7600 
* %T = ó transmission 
+ OD = optical density 
71. 
5. The effect of increasing the p- hydroxydiphenyl concentration 
Were there insufficient PP present to combine with the 
acetaldehyde, the colour would not develop properly at high LA 
concentrations. To test this an experiment was done using 0.2 
mls. PP (i.e. PP concentration doubled.) 0 -30 pg LA / tube were 
used with no CuSO4 - Ca (OH) treatment. The colour was read in 
the SP 500. The results are shown in table 32 and Fig. 18. The 
graph suggests that under these conditions there is a direct 
relationship between the OD and the LA content of the tubes. 
6. The accepted standard lactic acid curve 
Since the expected range of LA concentration per tube was in 
the range of 0 -10 i.g, three experiments were done over this range 
with the CuSO4 - Ca(OH)2 treatment included, and using 0. 2 mls. 
PP. The results are shown in table 33 and Fig. 19. The graph 
shows a good straight line which was calculated as: 
y = 0.0764 x + 0.00691 
7. Conditions to be used in future estimations of lactic acid 
The method used was as described previously with the 
exceptions that: 
i) 0.2 mls. of PP were used; 
ii) all colour measurements were made using the SP 500 
spectrophotometer; 
iii) on the few occasions that the7T was less than 10% (O.D. 
greater than 1. O)tdilution was made with H2SO4 such that 
the OD was less than 0.7. 
LEUKOCYTE LACTIC ACID PRODUCTION UNDER AEROBIC 
AND ANAEROBIC CONDITIONS. 
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TABLE 34. AEROBIC LACTIC ACID PRODUCTION OF LEUCOCYTES 
Incubation 
period - mins. 
% 
Transmission 
Lactic acid produced 
10 µM/1O leucocytes 














TABLE 35. ANAEROBIC LACTIC ACID PRODUCTION OF LEUCOCYTES 
Incubation 
period - mins. 
% 
Transmission 















LACTIC ACID PRODUCTION OF LEUCOCYTES - 
PRELIMINARY EXPERIMENTS: 
1. Aerobic lactic acid production of leucocytes 
This experiment was done to make certain that the leucocyte 
LA production was measurable. 
20 mis . of human peripheral blood were taken and anti - 
coagulated with 10 U / ml. heparin. The erythrocytes were 
sedimented with dextran. The erythrocyte -poor supernatant was 
centrifuged, the leucocytes being resuspended in 'phosphate' 
Hanks at pH 7.4. Two mis. of the leucocyte suspension + 2.0 ml. 
plasma were placed in Warburg flasks and incubated in the normal 
manner. One flask was removed every 30 minutes, the LA 
content being estimated in duplicate. The results are given in 
table 34 and Fig. 20. The LA production was found to be linear 
with time. 
2. Anaerobic lactic acid production of leucocytes 
The above experiment was repeated out of interest under 
approximately anaerobic conditions. The leucocyte suspension was 
placed in a stoppered tube at 37°C and shaken frequently, aliquots 
being withdrawn at intervals for LA estimation. The results are 
shown in table 35 and Fig. 20. The LA production under 
anaerobic conditions was found to be greater than under aerobic 
conditions as would be expected. The explanation of the low 
73. 
gradient over the time 0 -30 minutes is possibly that the 
dissolved oxygen was being utilised. 
3. Conclusions 
It was concluded that the amount of LA produced during the 
oxygen uptake incubation period would be measurable. 
THE EFFECT OF AMIDOPYRINE AND THIOURACIL ON 
LEUCOCYTE LACTIC ACID PRODUCTION 
A number of experiments were performed to study the 
effects of amidopyrine and thiouracil on the oxygen uptake and 
LA production of separated leucocytes. These results will 
be given later. The important observation was that while the 
results obtained for the effects of these drugs on PMN LA 
production were acceptable, the lymphocyte results were quite 
unintelligible, being very erratic and with duplicate 
determinations being widely different. This was probably due to 
the lymphocyte LA production being lower than the PMN LA 
production, consequently experimental errors would have a more 
marked effect. 
It was therefore considered necessary to use another method 
for the determination of the leucocyte LA production. The 
method chosen was the Biochemicaa enzymatic method which was 
a Biochemica Test Combination for Lactate determination. UV 
method. Boehringer Corp. (London) Ltd. 
74. 
obtained in a kit form, this method not being known about at the 
beginning of this work. 
LACTATE DETERMINATION - BIOCHEMICA METHOD 
1. Principle of the method 
This method depends upon the oxidation of L- lactate by 
nicotinamide adenine dinucleotide (NAD) to pyruvate, the reaction 
being catalysed by lactate dehydrogenase (LDH) (Hohorst 1965): 
L (+)- lactate + NAD+ pyruvate + NADH + H+ 
The equilibrium of this reaction lies to the left. In order to 
make the reaction proceed to the right, so giving a quantitative 
oxidation of the lactate, the protons are removed by use of an 
alkaline solution, while the pyruvate is trapped as the hydrazone: 
LN-lactate +NAD++hydrazine pH9H0 >pyruvate hydrazone +NADH 
+ H3o 
3 
The course of this reaction is measured spectophotometrically by th 
increased optical density due to the formation of NADH. 
Z. The method 
Three solutions were provided: 
solution 1 - 0.5M glycine buffer, pH 9.0, containing 
0. 4M hydrazine; 
solution 2 - 2 mg /ml. LDH; 
solution 3 - 0.027M NAD. 
The sample to be estimated was deproteinised by addition of 
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µg LACTATE / 0.1 ml 
Fig.21. RELATION BETWEEN LACTATE CONCENTRATION 
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µg LACTATE / 0.1 ml 
Fig.22. RELATION BETWEEN LACTATE CONCENTRATION 
AND OPTICAL DENSITY, THE STANDARD CURVE. 

































































































































































































































































































































































































































































































































































































































































































































































































diluted to 100 mis. with distilled water). The solutions were 
pipetted into small tubes as follows: 






0. 20 mis. 
After mixing, the tubes were incubated for one hour at 25 °C) 
the % transmissions then being measured at 366 mµ in 1 cm. light 
path glass cuvettes in a Unicam SP 500 spectrophotometer. 
The % transmissions were measured against an air blank. 
A solution blank was made up using 0.1 ml. of trichloracetic acid in 
place of 0.1 ml. of the deproteinised supernatant. 
A standard lactate solution was provided (1N L- lactate), a 
1:1000 dilution giving a solution containing 9 µg L- lactate /0.1 ml. 
3. The standard curve 
To see over what range the relationship between OD and 
lactate concentration was linear, the OD was determined for lactate 
concentrations of 0 -90 .i.g lactate /0.1 ml. sample. These results 
are given in tabe4 35 and Fig. 21. The curve appears to be linear 
up to about 25 i.g /0.1 ml. 
The test was repeated over the range 0 -18 i.g /0.1 ml. which 
was the expected experimental range. These results are given in 
table 37. Fig. 22 shows the combined results from tables 36 and 
76. 
37. It can be seen that the curve is linear over this range having 
as its best straight line the equation 
y = 0.01495x - 0.000493 
This line was taken as the standard lactate curve. 
THE EFFECT OF AMIDOPYRINE ON LEUCOCYTE LACTIC ACID 
PRODUCTION ESTIMATED USING BOTH METHODS. 
It was in the course of the experiments where the effects of 
differing concentrations of amidopyrine upon the leucocyte LA 
production were being investigated, that the defect of Barker and 
Summerson's method was first noticed. These LA determinations 
were then repeated using the Biochemica method of estimation. 
The results for these determinations are shown in table 38 and Fig. 
23, the effects of the drug being expressed as the % inhibition, 
where 
'no -drug' value - 'drug'value x 100 ,o inhibition ( %I) _ 
'no -drug' value 
It can be seen from Fig. 23 that both methods give 
essentially similar results for the PMN, while there is no 
similarity between the results for the lymphocytes. 
THE EFFECT OF THIOURACIL ON LEUCOCYTE LACTIC ACID 
PRODUCTION ESTIMATED USING BOTH METHODS 
Following on from the experiments mentioned above, the 
EFFECT OF AMIDOPYRINE ON LEUKOCYTE 









2 10 10 10 10 
AMIDOPYRINE CONC0 -MOLAR 








-60 - LYMPHOCYTES 
105 10 10 
12 
10 
AMIOOPYRINE CONC 0 - MOLAR 
FIG 23 -b 
EFFECT OF THIOURACIL ON LEUKOCYTE 
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FIG 24 -b 
BIOCHEMICA METHOD 
BARKER AND SUMMERSON'S METHOD A - - -. -A 
Figure 23a. Effect of amidopyrine on leucocyte respiration. 
" 23b. Effect of amidopyrine on leucocyte lactic acid production. 
Figure 24a. Effect of thiouracil on leucocyte respiration. 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































effects of thiouracil on leucocyte LA were determined using both 
methods for LA measurement. These results are shown in table 
39 and Fig. 24. As with amidopyrine, the PMN results do not 
differ with the two methods. The effects of thiouracil would appear 
to vary depending upon which method is used to estimate the LA 
produced. 
BIOCHEMICA METHOD Vs. BARKER AND SUMMERSON'S METHOD 
1. Polymorphs 
Either method would appear suitable for measuring PMN 
LA production, the Biochemica method giving less variation 
between duplicate experiments. 
2. Lymphocytes 
As can be seen from Figs. 23 and 24 the results obtained 
for the influence of amidopyrine and thiouracil depend entirely 
upon which method is used for the determination of the LA. 
produced. The Biochemica method gives reasonably reproducible 
results in both cases showing a trend with increasing concentration 
of the drugs. Barker and Summerson's method, on the other hand, 
gives results which are not reproducible, the scatter of the results 
being so great that no trend with increasing drug concentration is 
observable. These latter results may be due to this method 
being insensitive at the low LA levels found, or possibly to the 
78. 
presence of impurities which contribute a relatively large amount 
of "LA" relative to the amount of LA produced by the lymphocytes. 
It was therefore decided that the Barker and Summerson 
method should be discontinued, the Biochemica method being 
adopted instead. 
The significance of the effects of amidopyrine and thiouracil 
on leucocyte LA production will be considered later. 
THE CORRECTION FOR ERYTHROCYTE CONTAMINATION OF TH 
TWO LEUCOCYTE SUSPENSIONS DURING THE DETERMINATION 
OF THE LACTIC ACID PRODUCTION 
It was shown previously that the erythrocyte contamination of 
the two leucocyte suspensions contributed a negligible amount to 
their AO2's. It was assumed that the erythrocyte LA production 
would be small compared to the leucocyte LA production. When 
almost all the drug experiments had been done it was apparent that 
a simple explanation for the curious lymphocyte results would not 
be forthcoming. It was decided to check that the above assumption 
was correct. Eight experiments were performed to determine 
the erythrocyte LA production, the results being shown in table 
40, the LA production being expressed as ALA = 11M /hour /1010 
cells. 
79. 
Table 40. The lactic acid production of different cell types 






































Assuming an average leucocyte : erythrocyte ratio of 4:1 as 
determined previously, the erythrocytes would account for about 6. 2 
µM in every 4 x 862.6 µM produced. This is equivalent to about 
0.18% which is negligible. 
2. GerFeetion for erythrocyte contamination of the lymphocyte 
suspension 
Assuming an average leucocyte : erythrocyte ratio of about 
1 : 9 as determined previously, the/érythrocytes would account for 
bout 6.2 x 9 N.M in every 154.4 µM LA produced. Thus the true 
80. 
leucocyte LA production would be 154.4 - (6.2 x 9) = 98.6 µM LA. 
This is only 63.8% of the observed value. On attempting to 
correct past results by this percentage negative results were 
obtained in many cases for the lymphocyte ALA, while the PMN 
ALA was virtually unaffected. 
3. Conclusion 
This method for correcting for theerythrocyte contamination 
of the lymphocyte suspensions gave results which were extremely 
variable and quite uninterpretable. It was thus necessary to 
attempt another method for evaluating the erythrocyte contribution 
to the leucocyte LA. production. 
4. The use of three leucocyte suspensions 
Since the two leucocyte suspensions contained three cell 
types, (erythrocytes, lymphocytes, and PMN) it was thought that 
the LA production of the three cell types could be evaluated by 
using three leucocyte + erythrocyte suspensions and determining 
the LA production of each cell type by applying simultaneous 
equations in the manner detailed previously. The cell suspensions 
used were those following column separation and one obtained prior 
to the separation. This method for eliminating the erythrocyte 
contribution to the leucocyte LA production was not successful, 
some "no- drug" and "with- drug" values in the same experiment 
81. 
being as different as -2000 and -2000 p,M /hour /1010 lymphocytes. 
It was therefore concluded that this method for correcting for the 
erythrocyte contamination of the lymphocyte suspension was not 
going to be successful, though the reason for this was not clear. 
It was not possible, therefore, to obtain any results 
for the effects df drugs on lymphocyte LA production. 
SUMMARY OF 'NO -DRUG' RESULTS 
1. Polymorph lactic acid production 
It was mentioned previously that when the effects of drugs 
upon leucocyte lactic acid production were being investigated, 
control experiments were done simultaneously, and that this 
resulted in a number of 'no -drug' (control) results. A similar 
situation existed for the leucocyte LA determination. Table 41 
shows the PMN LA production in 36 'no -drug' determinations 
(column 4), the mean value being 918.5 N.M /hour /10 
10 
PMN. For 
comparison, Hedeskov and Esmann (1966) using column separated 
PMN found a value of 640 µM, while Rauch et al (1961) using a 
suspension consisting predominantly of PMN obtained a value of 
403 µM. 
2. Leucocyte crowding 
It was shown previously that as the PMN concentration 
increased, the AO2 decreased. A similar effect has been shown 
to exist for PMN lactic acid production in the past (Esmann, 1964). 
To ascertain if a crowding effect was present in these experiments 























LACTIC ACID PRODUCTION 
CORRELATION 
so 
COEFFICIENT : r _ -0-485. 
SIGNIFICANT AT P< 0.01 
10 11 1.2 13 1.6 1.5 1.6 
LOG 10 ( POLYMORPH CONCENTRATION. ) 
Figure 25. 
TABLE 41. INFLUENCE OF CELL CONCENTRATION ON POLYMORPH LACTIC ACID PRODUCTION 
Experiment 
number 
Number of * 
polymorphs 
x 106 






polymorphs z7 B 
Log B 
10 
95 17.7 1.2480 866 2.9370 
96 12.9 1.1106 774 2.8882 
98 36.9 1.5670 557 2.7461 
99 30.2 1.4800 775 2.8891 
100 17.6 1.2442 907 2.9572 
101 12.1 1.0831 913 2.9607 
102 13.8 1.1399 1042 3.0178 
103 15.3 1.1853 969 2.9864 
104 13.8 1.1386 828 2.9178 
105a 17.0 1.2304 893 2.9509 
106a 13.2 1.1189 1068 3.0286 
107 15.8 1.1973 1158 3.0637 
108 13.0 1.1127 884 2.9464 
109 21.3 1.3284 957 2.9809 
110 15.8 1.1973 1445 3.1599 
112 33.9 1.5302 879 2.9439 
113 16.7 1.2227 1116 3.0476 
114 11.3 1.0546 1014 3.0059 
115 19.6 1.2918 797 2.9016 
116 22.7 1.3564 524 2.7916 
117 11.2 1.0487 937 2.9717 
119 20.5 1.3118 947 2.9762 
120 20.4 1.3086 819 2.9133 
122 28.3 1.4518 947 2.9764 
123 12.7 1.1038 818 2.9125 
124 27.0 1.4314 931 2.9687 
125 20.4 1.3096 831 2.9196 
126a 15.1 1.1793 877 2.9431 
126b 15.1 1.1793 877 2.9431 
127 10.4 1.0153 823 2.9155 
128 13.0 1.1127 1061 3.0257 
129 12.4 1.0934 1307 3.1161 
130 25.5 1.4057 850 2.9296 
131 18.7 1.2718 868 2.9384 
132 15.9 1.2014 1150 3.0605 
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Figure 26. 
Relation between oxygen uptake and 
lactic acid production 
of leucocytes. 




in µL /hour /1010 
polymorphs 
Lactic acid production 
in LM/hour /1010 
polymorphs 
86 1168 879 
87 844 920 
88 857 884 
89 1477 897 
95 2084 865 
96 2566 773 
99 860 775 
100 1342 906 
101 1568 914 
102 1777 1042 
104 1592 828 
108 1716 1068 
110 1484 884 
112 1000 879 
113 2229 1116 
114 2357 1014 
116 1091 896 
117 1965 797 
119 2072 947 
120 1209 818 
122 1613 948 
123 1153 818 
124 1457 931 
125 1454 831 




(LA. production in µM /hour /10 10 PMN). This is shown in Fig. 25, 
the figures plotted being in table 41. The calculated'best straight 
line through the points was 
Y = - O. 268 X + 3. 288 
with a correlation coefficient (r) _ -0.485, which is significant at 
p < 0.01 (at p = 0.01, r = 0.4238. 
It was stated earlier that the cause of the crowding effect is 
not known. 
3. The relation between leucocyte oxygen uptake and lactic acid 
production 
It was of interest to see if there was any relation between 
PMN A O2 and ALA. 
Assuming that all PMN have the same X02 : ALA ratio, but 
that the metabolic rates of the leucocytes varies, then one would 
expect to find a linear relation with a positive gradient on the graph 
of 002 vs. ALA. If on the other hand there were no relation betwee 
A02 and ALA, i.e. these parameters varied independently from 
sample to sample, then one would not expect to find any correlation. 
To determine which was the case, a graph (Fig. 26) was plotted ten. oÇ 
the oxygen uptake in µL /hour /1010 PMN against the lactic acid 
production in µM /hour /1010 PMN, the appropriate values being given 
in table 42. The equation of the best straight line was calculated 
83. 
as 
Y = 0.0556X+817.07 
with the correlation coefficient (r) = 0.279 which is not significant 
at p = 0.1 (at p = 0.1, r = 0. 3172). It would thus seem that there is 
no direct relation between these two parameters. There are a 
number of possibilities to explain this result: - 
I) The PMN may have been damaged during the separation 
process. Since leucocytes exhibit the Pasteur effect, damage to 
the respiratory mechanism would result in an increased LA 
production, this leading to a degree of scatter between the results. 
Fig. 26 does show considerable scatter. 
II) The crowding effect is more pronounced on the LA 
production (r = approx. -0.5) than on A02 (r = approx. -0.3). 
Thus as the PMN concentration increases there will be a greater 
decrease in ALA than in AO2. In consequence there will be a 
lower gradient for the line than might otherwise be expected. 
III) It is also possible that there really is no correlation 
between the parameters. It is believed by a number of workers 
that the production of LA by leucocytes "in vitro" is an artefact 
of separation, and that under normal "in vivo" conditions leucocyte 
produce no LA (Seelich, 1962). If this is the case, no correlation 
would be expected. 
84. 
It is difficult to ascertain what is the normal ratio of 
A02 : ALA, due to different workers using a variety of methods 
for leucocyte separation, for .AO2/ALA estimations, and using 
different incubation media. For instance McKinney et al (1952) 
using unseparated leucocytes with a "great majority" of PMN 
found a ratio of 1.0 µM 02 used for every 8.0 µM LA produced 
in a medium of 1 part plasma to 5 parts Hanks. Beck (1958) 
using homogenised unseparated leucocytes in a medium fortified 
by addition of ATP, DPN, and cytochromec found a ratio of 11. 3 
: 1.0, while Hedeskov and Esmann using column separated PMN 
and a Tris- phosphate -buffered plasma -free medium obtained a 
ratio of 5.5 : 1.0. In this work the ratio was 1.3 : 1.0. 
From these figures it is apparent that there is no obvious 
relationship between oxygen uptake and lactic acid production. 
SECTION 4. THE EFFECTS OF DRUGS ON LEUCOCYTE 
RESPIRATION AND LACTIC ACID PRODUCTION 
PROCEDURE AND RESULTS 
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SECTION 4. THE EFFECTS OF DRUGS ON LEUCOCYTE 
RESPIRATION AND LACTIC ACID PRODUCTION 
PROCEDURE AND RESULTS 
THE USE OF DRUGS 
The following drugs were investigated for their effects on 




the main blood dyscrasia induced 
by these drugs is agranulocytosis 
phenylbutazoned (PB) which induces agranulocytosis and 
aplastic anaemia with equal frequency. 






these drugs are not generally 
associated with haematological 
disorders 
All drug solutions were made up in 'phosphate' Hanks 
immediately prior to use after it had been found that a stock 
solution of CAP lost all its inhibitory activity with regard to PMN 
respiration in three days (see also Higuchi et al 1954). The 
resulting solutions were adjusted to pH 7.4 where necessary with 
O.1N HC1 or o.1N NaOH. All drugs were investigated at the same 
85a. 
a - chlorpromazine HC1 (Largactil), May and Baker Ltd., 
b - amidopyrine was supplied by Geigy (U.K.) Ltd. 
c.- thiouracil was supplied by Koch -Light Ltd. 
d - phenylbutazone was supplied by Geigy (U.K.) Ltd. 
e - chloramphenicol succinate (chloromycetin), Parke Davis 
and Co. Ltd. 
f - tetracycline HC1 (Achromycin), Lederle Laboratories. 
g - sulphisoxazole (GantrisinL Roche Products Ltd. 
86. 
concentrations, these being 1.0 x 10-2, 1.0 x 10-3, 1.0 x 10-4, 
and 1.0 x 10 -5 molar. Because of the high potency of CPZ 
this drug was also used at 1.0 x 10 -6M. CPZ, PB, and TC were 
not soluble at 1.0 x 10 -2M, the highest concentrations of these 
drugs used being 1.0 x 10 -3M. 
At all times when the effects of drugs on leucocyte 
respiration and LA production were being observed control 
determinations were carried out simultaneously. The 
procedure in each case was identical with the exception that the 
leucocytes were suspended in either drug -free or 'with -drug' 
medium. All determinations, including controls, were made in 
duplicate. Because of the large number of leucocytes required 
for the estimation of the oxygen uptake only one drug concentration 
and control could be investigated at any one time. Two 
experiments were conducted at each drug concentration. 
Having determined the various A02 and ALA values as 
described previously, the effects of the drugs were expressed 
in terms of the percentage inhibition (c%I), where 
%I = 'no- drug' EO2 /LLA - 'with -drug' 002 /ALA 
'no -drug' A02/ALA. 
The results were expressed in this form to eliminate the 
individual variation of the 'no -drug' A02 and ALA values. The 
87. 
î 
%L of the duplicate determinations carried out on different 
blood samples generally agreed to within 10%. 
Los -dose v. s response curves were drawn for each drug, 
the I being taken as the response. 
RESULTS 
The effect of the individual drugs on the leucocyte 
respiration and also on the PMN LA production are shown in 
tables 43a, b - 49a, b (the "a" tables showing the inhibition of 
leucocyte respiration, and the "b" tables the inhibition of PMN 
LA. production). The results are also presented in graphical 
form in Figs. 27 - 31. 
1. The effects of drugs on polymorph respiration 
It is readily apparent that there are distinct differences 
between the drugs with regard to their actions on PMN 
respiration on a molar basis. CPZ is about ten times as potent 
as any other drug tested, the order of potencies of the other drugs, 
in descending order, being AP greater than PB, PB being very 
similar to TU, with CAP being the least potent. TC and SO were 
inactive. 
2. The effects of drugs on lymphocyte respiration 
None of the drugs investigated showed any marked effect on 
lymphocyte respiration. 






















Effect of chlorpromazine on leucocyte respiration (L\ D2) 
and lactic acid production.C,L LA). 


















-3 127 1747 690 61 2298 2149 6 
1.0 x 10 128 2186 335 59 2834 2270 20 
-4 126 2682 1744 35 2829 2482 12 
1.0 x 10 133 1602 1000 38 2574 2625 -2 
-5 129 1323 1084 18 2804 2755 2 
1.0 x 10 130 2033 1546 32 3386 3366 1 
-6 131 1932 1512 22 2982 3096 -4 
1,0 x 10 132 1579 1406 11 2945 3163 -7 
* d02 expressed as 111 /hour /1010 leucocytes 
+ % I = % inhibition 












-3 127 823 896 -9 
1.0 x 10 128 1061 1063 0 
-4 126 1307 1548 -18 
1.0 x 10 133 850 952 -12 
-5 129 868 868 0 
1.0 x 10 130 - - - 
-6 131 1150 1203 -5 
1.0 x 10 132 701 731 -4 
10 
dLA expressed as µM/hour /10 leucocytes 
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AMIDOPYRINE CONC2 - MOLAR 
Figure 28. 
Effect of amidopyrine on leucocyte respiration(L - \02) 
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PHEN YLBUTAZONE CONCn - MOLAR 
Figure 29. 
Effect of phenylbutazone on leucocyte respiration (L \02) 
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Effect of thiouracil on leucocyte respiration W,02) 
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CHLORAMPHENICOL CONC0 - MOLA R 
Figure 31. 
Effect of' chloramphenicol on leucocyte respiration 0.02) 
and lactic acid production (61,A) . 
























80 570 468 18 2710 2828 -4 
81 864 617 29 3480 3386 3 
1.0 x 10 
-2 
82 893 534 34 2428 2171 11 
83 934 651 30 4035 3895 3 
84 1131 835 26 2987 2791 7 
85 949 500 47 2990 2726 9 
mean : 31 mean : 5 
-3 105a 1202 1153 4 2492 2410 4 
1.0 x 10 
105b 1438 1110 23 2989 2872 4 
_a 
y 
106 1254 1091 13 2524 2280 10 
1.0 x 10 
110 1484 1548 -4 3079 2738 -8 
108 1716 1530 11 2273 2184 4 
1.0 x 10 
-5 
109 1490 1600 -7 2310 2240 3 
* d02 expressed as µl /hour /1010 leucocytes 
+ %I = %inhibition 













1.0 x 10 
-2 
110 1445 1393 4 
110 1445 1393 4 
110 1445 1417 2 
1.0 x 10_3 
105b 893 995 -12 
106 1068 1069 0 
1.0 x 10_4 
110 1445 1447 -1 
-5 108 884 958 -8 
1.0 x 10 
109 987 957 3 
* LEA expressed as p.M/hour /1010 leucocytes 
+ %I = %inhibition 























122 1613 1460 9 2777 2697 3 
-3 123 1153 1403 -19 2822 2897 -3 
1.0 x 10 
124 1457 1464 - 1 3375 3412 -1 
125 1454 1452 0 2778 2841 -2 
-4 
1.0 x 10 
126a 1643 1605 2 1999 2062 -3 
126b 1643 1600 3 1999 1600 5 
* CO2 expressed as µl /hour /10 
10 
leucocytes 
+ %I = % inhibition 













122 948 887 6 
1.0 x 10 
-3 123 818 734 10 
124 931 912 2 
125 831 768 8 
126a 877 863 2 
1.0 x 10 
-4 
126b 877 879 0 
* i2A expressed as µM /hour /10 
10 
leucocytes- 









































































































































































































































































































































































































































































































































































































Polymorph LA production was apparently unaffected by all 
of the drugs tested. It was mentioned previously (page2 -o) that 
leucocytes show a Pasteur effect, so it might be expected that a 
drug- induced inhibition of respiration would stimulate LA. 
production. The fact that this was not observed suggests one of 
two possibilities: - 
i) that the drugs inhibit PMN respiration in such a 
manner that the LA production is unaffected; this implies that 
no Pasteur effect is operating, or 
ii) that the drugs exert a depressant action on both 
respiration and glycolysis, the depression of glycolysis not being 
observed due to the depressed respiration concurrently 
stimulating glycolysis, i.e. a Pasteur effect is operating. 
SECTION 5. SUMMARY AND DISCUSSION 
SUMMARY OF SECTIONS 1 -4. 
The purpose of this work as described in Section I was to 
investigate the actions of drugs known to induce agranulocytosis 
on the metabolism of human leucocytes. Some of the current 
theories as to the aetiology of agranulocytosis were discussed, 
and it was concluded that the underlying factors predisposing 
individuals to attacks of this dyscrasia were unknown. Since a 
number of conditions have been demonstrated to have hereditary 
connections it is possible that a similar process occurs in 
agranulocytosis. Thus a secondary investigation was to be a 
comparison of the effects of these drugs on normal leucocytes and 
on leucocytes obtained from drug- sensitive individuals and their 
siblings to determine whether any hereditary factor could be 
demonstrated with regard to the susceptibility of leucocytes to 
the in vitro" actions of the drugs. 
Section 2 dealt with the experimental procedure for the 
separation of lymphocytes and polymorphonuclear leucocytes 
(PMN) from whole blood and also for the measurement of the 
respiration of the separated cells. The bulk of the erythrocytes 
were removed by sedimentation with dextran, the resulting 
erythrocyte -poor leucocyte suspension being concentrated by 
centrifugation and resuspension of the leucocyte sediment in a 
smaller volume of the supernatant. The two leucocyte types were 
89. 
90. 
separated by means of a column of small glass beads, the 
principle of this procedure being that in the presence of fresh 
plasma, and calcium and magnesium ions, PMN will adhere to 
siliconed glass surfaces while lymphocytes (and erythrocytes) will 
not. Thus, following addition of the leucocyte -rich suspension to 
the glass bead column and incubation at 37°C for 30 minutes, the 
PMN adhered to the beads; the lymphocytes could be recovered 
by washing the column with a 20% plasma - 80% Hanks solution. 
Subsequent washing of the column with a plasma -, calcium -, and 
magnesium -free solution containing 0.02% ethylene diamine 
tetraacetic acid allowed the PMN to be recovered. 
The final yeíld of leucocytes relative to the total initial 
number started with was not large. The dextran sedimentation 
of the erythrocytes led to a 38% loss of leucocytes, the 
differential count (%PMN : %lymphocytes) being altered slightly 
in favour of the PMN. On average about 30% of the PMN and 
36% of the lymphocytes were recovered from the whole blood 
samples. The final lymphocyte suspension had a composition of 
9 PMN : 91 lymphocytes : 890 erythrocytes, the corresponding 
figures for the PMN suspension being 93 : 7 : 24. 
The oxygen uptake of the separated leucocytes was 
measured using a standard Warburg apparatus, it being necessary 
to use a minimum of 20 - 30 x 106 leucocytes per flask to produce 
91. 
a measurable oxygen uptake over a two hour period. The 
incubation medium was 50% plasma : 50% Hanks solution with 
the phosphate buffer strength being increased to prevent the pH 
rising above its initial value of 7.4. The oxygen uptake was 
generally linear after the first thirty minutes, a somewhat higher 
rate being found over the 0 - 30 minute period. The erythrocyte 
contamination of the leucocyte suspensions was found to exert a 
negligible contribution to the oxygen uptake. The mean rate of 
oxygen uptake as determined over the 30 - 90 minute period 
(002) was found to be 
LO2 PMN = about 1500 µl /hour /1010PMN 
AO lymphocytes =about 2700 µl /hour /1010 lymphocytes. 
These values for AO2 were somewhat lower than those found by 
other workers, possible explanations being considered at the end 
of Section 2. 
A crowding effect, where the AO2 is depressed as the 
leucocyte concentration increases, was observed for both 
leucocyte types, it being sigrficant at the 10% level for PMN, but 
not significant for lymphocytes. 
Section 3 details the determination of the leucocyte lactic 
acid (LA) production. Chemical estimation was found to be 
unsatisfactory, an enzymatic method proving more accurate. For 
92 
reasons which were described it wa s not possible to estimate the 
lymphocyte LA production. The mean rate of LA production 
(ALA) for the PMN was found to be about 920 µM /hour /1010PMN. 
A sigrificant (p < 0.01) crowding effect was demonstrated. 
In all experiments where the effects of the drugs on AO2 
and ALA were being determined, both 'no -drug' and 'with -drug' 
values were measured, the effect of the drug being expressed as 
the percentage inhibition ( %l) = ('no -drug' A02/ALA - 'with -drug' 
AO2 /ALA) / 'no -drug' AO2 /G LA. This resulted in a number of 
'no -drug' values for 002 and ALA from which the mean values 
given above were calculated. 
The drugs investigated were chlorpromazine, amidopyrine, 
and thiouracil which all induce predominantly agranulocytosis, 
phenylbutazone which causes agranulocytosis and aplastic anaemia 
with equal frequency, and chloramphenical which induces mainly 
aplastic anaemia. Two drugs which are responsible for blood 
dyscrasias very infrequently - tetracycline and sulphisoxazole - 
were also used. 
The results of these experiments are summarised in 
tables 50, 51, and 52, and in Figs. 32, 33, and 34. In all cases 
only the means of the two duplicate determinations at each drug 
concentration are shown. It is apparent that lymphocyte A02 












AP = AMIDOPYRINE 
PB = PHENYLBUTAZONE 
CPZ = CHLORPROMAZINE 
TU = THIOURACIL 
CAP = CHLORAMPHENICOL 
TC = TETRACYCLINE 
SO = SULPHISOXAZOLE 
CPZ 
AP 
- TC - SO 
10-6 10 -5 10 
-4 
10 -3 10 -2 















































































































































































































































































































































































AP = AMIDOPYRINE 
PB = PHENYLBUTAZONE 
CPZ = CHLORPROMAZINE 
TU = THIOURACIL 
CAP = CHLORAMPHENICOL 
TC = TETRACYCLINE 
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LACTIC ACID PRODUCTION 
Ag, = AMIDOPYRINE 
P = PHENYLBUTAZONE 
CPZ = CHLORPROMAZINE 
TU = THIOU RAC IL 
CAP= CHLORAMPH ENICOL 
TC = TETRACYCLINE 







10-6 10 -5 10 -4 10 -3 10 -2 




















































































































































































































































































































































































and PMN ALA were unaffected by any of the drugs tested, while all 
the drugs which induce haematological disorders showed inhibitory 
tendencies to PMN L O2. 
DISCUSSION. 
The literature indicates that the normal therapeutic plasma 
levels of these drugs are in the range 10 -4 - 10 -5 M. Thus it migh 
appear that some of these drugs would have the potential to inhibit 
PMN respiration 'in vivo'. However, these plasma levels refer to 
the total amount of drug in the plasma and not to the amount of free 
drug present. The degree of plasma binding controls the amount 
of free drug present. The following tables show: 
i) the inhibition of PMN respiration at the therapeutic 
plasma level assuming no plasma binding, and 
ii) the inhibition of PMN respiration which might be 
expected to occur 'in vivo' taking into account the degree of plasma 
binding. 





%I of PMN respirati.n 







1.0 x 10 -6 (1) 
5.0 x 10 -5 (1) 
5.0 x 10 -5 (2) 
2.4 x 10 -5 (3) 
_8 
3.3 x 10 - (4) 
_4 















Degree of plasma 
binding - % 
Therapeutic plasma 
concentration of 
free drug - Molar 
very high, say 
95. (6) 
5.0 x 
2.5 x 10 
4.2 x 10 
1.2 x 10 
3.3 x 10 
4.$ x 10 

























Huang and Kurland (1961) 
Brodie and Axelrod (1950) 
Burns et al (1953) 
Paschkis et al (1945) 
Glazko et al (1949) 
Salzman and Brodie (1956) 
Friend (1957) 
Goodman and Gilman (1965) 
The low dose is that administered for sedative purposes, 
the high dose being given to psychotic patienti. 
It will be observed that all the drugs which have a tendency 
to induce agranulocytosis, that is CPZ, AP, and TU all inhibit 
PMN respiration in vitro' at concentrations which would be 
expected to be present normally 'in vivo'. 
94. 
95. 
If a comparison is made between these latter results and 
the incidence of agranulocytosis relative to aplastic anaemia 
induced by these drugs, the appropriate figures being shown in 
the table below, a correlation is apparent. Drugs which induce 
agranulocytosis but not aplastic anaemia, that is CPZ, AP, and 
TU, inhibit PMN respiration 'in vitro', while PB, which induces 
both these dyscrasias about equally, exerts a much lesser 
inhibitory effect on PMN respiration. The drug inducing 
predominantly aplastic anaemia, CAP, had no effect on PMN 
respiration. Drugs not generally inducing haematological 
d.sorders SO and TC, were also inactive as regards PMN 
respiration. These findings suggest that there may be some 
common factor between drugs which are liable to cause 
agranulocytosis. 
Number of cases of the indicated dyscrasia 
Drug due to the drug alone 
Aplastic anaemia Agranulocytosis 
CPZ 83 3 
AP 15 1 
TU 23 o 
PB 17 17 
CAP 18 154 
Figures from A.M.A. Registry on Adverse Reactions. 
96. 
It was shown previously that the mechanism of 
agranulocytosis in AP- sensitive individuals is reasonably well 
understood though the reason why certain people are sensitive 
remains obscure. Although CPZ, AP, and TU all exhibit 
similar 'in vitro' effects, with variations in potency, they do not 
all seem to be identical with respect to their property of inducing 
agranulocytosis. For instance, although AP, when administered 
to a drug- sensitive patient as a single minute dose, produces a 
rapii and profound fall in the circulating PMN, CPZ under similar 
conditions must be administered as a number of quite large doses 
A further difference is that although AP- induced agranulocytosis 
is associated with the presence of leukoagglutininis, which is 
suggestive of an immune response, there is only a single report 
ci 
of a CPZ- induced leukoagglutinin (HoffmanL1963), which suggests a 
direct toxic action for this drug. Alternatively, the methods 
used for the demonstration of leukoagglutinins may not be 
sufficiently sensitive, though this is improbable. In view of these 
differences in the manner in which agranulocytosis is apparently 
induced by these drugs, caution must be exercised when attempting 
to interpret the present results, particularly since the respiratory 
process involves a multitude of enzyme systems. Thus although 
CPZ, AP, and TU all show similar actions on PMN respiration, 
they may in fact all be acting in different ways. 
97, 
One could list all the known actions of these drugs on 
specific enzymes in an endeavour to find common actions, but this 
approach is not likely to yield much information because of the 
wide variety of enzyme sources and methods used. For 
instance, TU inhibits cytochrome c of rat thyroid but not of rat 
liver and marrow (Paschkis et al 1945), while CPZ inhibits 
cytochrome c from rat liver mitochondria and inhibits the 
respiration of brain slices but not of kidney and liver slices 
Peruzzo and Forni (1953) ® PB does not act on rat liver mitochondria 
(Stenger 1956). 
What is required, therefore, is a systematic study of the 
effects of these drugs on leucocyte metabolism, these studies 
being conducted using specific substrates and enzyme systems. 
Since this type of work would be carried out on cell -free systems, 
it would also be possible to determine whether the different 
results obtained in this work for the effects of the drugs on 
lymphocyte and PMN respiration were due to the two cell types 
having different respiratory systems, or to the drugs failing to 
penetrate the lymphocyte membrane. It may be that the drugs 
are acting on the membrane, by inhibiting transport mechanisms 
which are essential for PMN but not for lymphocytes. Since a 
method for separating marrow elements has recently been evolved 
98. 
(Morrison 1967) similar useful work could be conducted using the 
immature cells of the myeloid and lymphoid series. Using un- 
separated human marrow it has been shown (Park, 1968) that AP 
exerts a similar inhibitory effect on the respiration to that found 
for peripheral leucocytes. The contamination of the marrow 
with peripheral leucocytes was considerable, so the apparent 
inhibition of respiration may be just a reflection of the action of 
the drug on the peripheral leucocytes. 
It was found impossible to obtain any blood samples from 
drug- sensitive patients, so no investigations into the occurrence 
of any possible hereditary factors wa-s made. One supposedly 
normal female blood donor gave a remarkable response to 
tetracycline. As mentioned previously TG had no action on 
leucocyte respiration nor on PMN LA production in four 
experiments. On using this womaris leucocytes, 1.0 x 10 -3 M TC 
was found to cause complete inhibition of PMN respiration, PMN 
LA production and lymphocyte respiration being unaffected. 
According to her doctor she had no history of having taken any 
tetracycline drugs. On repeating this experiment on a fresh blood 
sample about six months later, and sacrificing duplicate 
determinations so that more drug concentrations could be used, 
-3 -4 -5 (1. 0 x 10 M) essentially identical results were obtained, 
99. 
the PMN respiration being inhibited by 80% at 1.0 x 10 -3M but 
not at 1.0 x 10 -4M, the other two parameters being unaffected. 
Two requests to the womaris doctor for blood samples from her 
siblings produced no response. It is probable that these 
particular PMN were abnormally sensitive to TC; it would be a 
remarkable if both results were due to experimental error. 
Whether the donor had in fact taken tetracyclines at a much 
earlier date and had become sensitive to the drug, or whether her 




This work was carried out in order to investigate the actions 
of drugs known to induce agranulocytosis on certain metabolic 
reactions of human leucocytes. Lymphocytes and polymorphon- 
uclear leucocytes (PMN) were separated "in vitro" from samples 
of normal human blood, utilising the property of PMN whereby they 
will adhere to siliconed glass surfaces while lymphocytes do not 
adhere. The respiration and lactic acid production of the separated 
leucocytes was measured using manometric and enzymic methods 
respectively. It was found that drugs inducing predominately 
agranulocytosis - chlorpromazine, amidopyrine, and thiouracil - 
inhibited PMN respiration by 20% at concentrations which occur 
"in vivo" under normal therapeutic conditions. Drugs inducing 
both agranulocytosis and aplastic anaemia - phenylbutazone and 
chloramphenicol - showed little inhibitory activity on PMN 
respiration. No drugs exerted any apparent effect on 
lymphocyte respiration and on PMN lactic acid production. The 
significance of these results was discussed. 
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